Publications & Works

Publication Network
Articles 179
All (179)
SCI-E, SSCI, AHCI (118)
SCI-E, SSCI, AHCI, ESCI (131)
ESCI (11)
Scopus (135)
TRDizin (48)
Other Publications (14)

1. Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey

YAYLA M. E., Okyar B., Ersözlü E. D., Özgür D. S., Bes C., ÇEFLE A., et al.
Clinical and Experimental Rheumatology , vol.44, no.8, pp.1562-1569, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Comparative analysis of inflammation and fever of unknown origin: Diagnostic processes and etiological spectrum

Özden İ., YAYLA M. E., SEZER S., USLU E., ATEŞ A., TURGAY T. M.
Medicine , vol.105, no.26, 2026 (SCI-Expanded, Scopus)

3. Predictive Factors for Relapse in Still's Disease: A Retrospective Cohort Study of Clinical and Laboratory Biomarkers

ÇAKIR İ. Y., ERDEN A., Mahmutoğlu Y., Kardaş R. C., USLU E., BÖLEK E. Ç., et al.
Clinical and Translational Science , vol.19, no.6, 2026 (SCI-Expanded, Scopus)

4. Familial aggregation in Behçet’s Disease: Sibling history as a risk factor for Neuro-Behçet

Ata E. B., ÇAKIR İ. Y., Eken A., Ergül Ç., Karaçalı E., Dalkılıç Y. E., et al.
Irish Journal of Medical Science , 2026 (SCI-Expanded, Scopus)

5. Interstitial Pneumonia with Autoimmune Features from the Rheumatologists’ Perspective; Single Center Experience

USLU E., Sahin D., Ilbay A., Yilmaz R., Gaydan A., Govec Giynas N., et al.
Diagnostics , vol.16, no.2, 2026 (SCI-Expanded, Scopus)

6. Can mycophenolate mofetil be an effective option in the treatment of vascular Behçet's Syndrome.

Uslu E., Göveç Giynaş N., Karaman Ongun Z., Sezer S., Yayla M. E., Turgay T. M., et al.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG , vol.42, no.4, pp.17166, 2025 (SCI-Expanded, Scopus)

7. Deep Learning Performance in Analyzing Nailfold Videocapillaroscopy Images in Systemic Sclerosis

Yayla M. E., Aydın A., Kılıçaslan M., Kalkan M., Güzel M. S., Shikhaliyeva A., et al.
DIAGNOSTICS , vol.15, no.22, 2025 (SCI-Expanded, Scopus)

8. Malignancy-associated risk factors in patients with systemic sclerosis

Baysal S., Şahin D., Sezer S., Yayla M. E., Uslu E., Ateş A., et al.
Journal of Scleroderma and Related Disorders , vol.10, no.3, pp.518-522, 2025 (ESCI, Scopus)

9. Ultrasonographic evaluation of hand and wrist joints in patients with systemic sclerosis

Ermancık Z., Yayla M. E., İlbay A., Göveç Gıynaş N., Sezer S., Uslu E., et al.
Journal of Scleroderma and Related Disorders , vol.10, no.3, pp.510-517, 2025 (ESCI, Scopus)

10. Is the Development of Hypo-Gammaglobulinemia Associated with Better Treatment Response in Patients with Rheumatoid Arthritis Using Rituximab?

Aydemir Guloksuz E. G., Sezer S., Sahin Eroglu D., Colak S., Kelesoglu Dincer A. B., Yayla M. E., et al.
Journal of clinical medicine , vol.14, no.19, 2025 (SCI-Expanded, Scopus)

11. Inflamed Pathways to Motherhood: Evaluating Obstetric and Neonatal Outcomes in Rheumatic Pregnancies

Turgay B., Zorlu U., Varlı B., Aynaoğlu Yıldız G., Baydemir Ş. K., Atabekoğlu C. S., et al.
JOURNAL OF CLINICAL MEDICINE , vol.14, no.16, 2025 (SCI-Expanded, Scopus) Sustainable Development

12. The effects of disease activity on sleep disorders in ankylosing spondylitis patients Ankilozan spondilitli hastalarda hastalık aktivitesinin uyku bozukluklarına etkisi

KARATAŞ A., TURGAY T. M., KÜÇÜKŞAHİN O.
Journal of Turkish Society For Rheumatology , vol.17, no.2, pp.92-101, 2025 (Scopus, TRDizin)

13. Impact of age at disease onset on clinical manifestations and prognosis in systemic lupus erythematosus Sistemik lupus eritematozusta hastalık başlangıç yaşının klinik belirtiler ve prognoz üzerindeki etkisi

Şahin D., Bulat B., Uslu E., Göveç Gıynaş N., Turhan G., Kader M., et al.
Journal of Turkish Society For Rheumatology , vol.17, no.2, pp.60-67, 2025 (Scopus, TRDizin)

14. CORTICOSTEROID USE IN EARLY SYSTEMIC SCLEROSIS: INSIGHTS FROM THE TURKISH SYSTEMIC SCLEROSIS DATABASE

UĞURLU Z., Okyar B., Ersozlu D., Ozgur D. S., Bes C., ÇEFLE A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus)

15. TREATMENT PREFERENCES IN EARLY SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: REAL-WORLD DATA FROM THE TURKISH SYSTEMIC SCLEROSIS REGISTRY

Bilici R., Okyar B., Ersozlu D., Ozgur D. S., Bes C., ÇEFLE A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

16. DISTINGUISHING CLINICAL FEATURES BETWEEN LIMITED AND DIFFUSE SUBTYPES IN EARLY-STAGE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IS CHALLENGING

TEMİZ KARADAĞ D., Okyar B., Ersozlu D., Yilmaz A., Bektas E., Bes C., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus)

17. PREVALENCE AND RISK FACTORS FOR CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH EARLY SYSTEMIC SCLEROSIS

Amikishiyev S., Okyar B., Ersoezlue D., Ozgur D. S., Bes C., ÇEFLE A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus)

18. DOES OVERLAP SYNDROME CONTRIBUTE TO CLINICAL DIFFERENCES IN SYSTEMIC SCLEROSIS SKIN SUBTYPES

Vasi I., Okyar B., Ersozlu D., Ozgur D. S., Bes C., Cefle A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

19. CLINICAL PREDICTORS OF TREATMENT DISCONTINUATION IN ADULT-ONSET STILL'S DISEASE

ÇAKIR İ. Y., Mahmutoglu Y., Kardas R. C., USLU E., SEZER S., YAYLA M. E., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

20. TRACING THE PATH TO DIAGNOSIS: INITIAL SYMPTOMS AND DELAYS IN SYSTEMIC SCLEROSIS FROM THETURKISH NATIONAL REGISTRY

Guler A. A., Baltaci M. A., Yazgan B. F., Okyar B., Avcu A., UĞURLU Z., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus)

21. TYPE I INTERFERON SIGNATURE IN LARGE VESSEL VASCULITIS; PRESENT OR IMAGINARY

USLU E., Ilbay A., Giynas N. G., Gaydan A., Ates E. S., DALVA K., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

22. EXPLORING THE ASSOCIATION BETWEEN AUTOANTIBODY PROFILES AND THE DEVELOPMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS PATIENTS: A COMPREHENSIVE ANALYSIS

Yamancan G., Karatas A., ERDEN A., Sari A., BABAYİĞİT A., Guler A. A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.84, 2025 (SCI-Expanded, Scopus) Sustainable Development

23. Evaluation of performance of the Still Activity Score for assessment of Adult-onset Still's Disease: Comparative study with Systemic Feature Score and Modified Pouchot-Activity Score.

Uslu E., Yayla M. E., Şahin-Eroğlu D., Atmaca-Haktaniyan B., Göveç-Giynaş N., Yilmaz R., et al.
Reumatologia clinica , vol.21, no.2, pp.501814, 2025 (Peer-Reviewed Journal)

24. Molecular analyses of MEFV gene mutation variants in Turkish population

Aksoy R., Us E., Aksoy D. F., Dumlupınar E., Turgay T. M.
MOLECULAR BIOLOGY REPORTS , vol.51, no.1, 2024 (SCI-Expanded, Scopus)

25. Rheumatoid Arthritis-Related Lung Disease and Its Association With Mortality

Şahin Eroğlu D., Çolaklar A., Baysal S., Torgutalp M., Baygül A., Sezer S., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.30, no.5, pp.177-182, 2024 (SCI-Expanded, Scopus)

26. Serum leukemia inhibitory factor (LIF) levels in patients with Takayasus and Giant cell arteritis: A cross-sectional study

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.
Reumatología Clínica (English Edition) , vol.20, pp.287-290, 2024 (ESCI)

27. Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study Niveles séricos del factor inhibidor de la leucemia en pacientes con arteritis de Takayasu y de células gigantes, un estudio transversal

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.
Reumatologia Clinica , vol.20, no.6, pp.287-290, 2024 (ESCI, Scopus)

28. Assessment of cardiac arrhythmias, P wave and QT dispersion in systemic sclerosis

Avanoglu Guler A., Akbulut M., uslu yurteri e., TULUNAY KAYA C., TURGAY T. M.
Medicine Science , vol.13, no.1, pp.153-158, 2024 (TRDizin) Creative Commons License

29. Are there differences in the clinical and laboratory features of patients with seronegative primary Sjögren's syndrome?

Yayla M. E., Aksoy R., Uslu E., Karaman Z., Yılmaz R., Ilbay A., et al.
Turkish journal of medical sciences , vol.54, no.5, pp.956-962, 2024 (SCI-Expanded, Scopus, TRDizin)

30. The Performance of 2023 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) Antiphospholipid Syndrome Classification Criteria in a Real-World Rheumatology Department

USTA A., YAYLA M. E., USLU E., SEZER S., US E., ATEŞ A., et al.
Mediterranean Journal of Hematology and Infectious Diseases , vol.16, no.1, 2024 (SCI-Expanded, Scopus)

31. Aksiyel spondiloartrtit hastalarında secukinumab deneyimi: Tek merkez 3 yıllık gerçek yaşam verileri

USLU YURTERİ E., ŞAHİN EROĞLU D., AYDEMİR GÜLÖKSÜZ E. G., İLBAY A., TURGAY T. M., KINIKLI G., et al.
Ulusal Romatoloji Dergisi , vol.15, no.3, pp.113-119, 2023 (Scopus, TRDizin)

32. Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre

Uslu Yurteri E., Şahin Eroğlu D., Aydemir Gülöksüz E. G., İlbay A., Turgay T. M., Kınıklı G., et al.
Ulusal Romatoloji Dergisi , vol.15, no.3, pp.113-119, 2023 (TRDizin)

33. Investigation of COVID-19 Vaccination and Disease Status in Behçet’s Patients

Yılmaz R., Sezer S., İlbay A., Göveç Gıynaş N., Aydemir Gülöksüz E. G., Gaydan A., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.76, no.3, pp.206-212, 2023 (Peer-Reviewed Journal)

34. Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance

Aydemir Guloksuz E. G., Sezer S., YAYLA M. E., Sahin Eroglu D., USLU YURTERİ E., Kelesoglu Dincer A. B., et al.
Journal of Clinical Rheumatology , vol.29, no.4, pp.177-182, 2023 (SCI-Expanded, Scopus)

35. The factors predicting development of serious infections in ANCA-associated vasculitis

USLU YURTERİ E., Sezer S., Torgutalp M., YAYLA M. E., Eroglu D. S., Okatan I. E., et al.
Sarcoidosis Vasculitis and Diffuse Lung Diseases , vol.40, no.2, 2023 (SCI-Expanded, Scopus)

36. The Relationship between Serum IL-17 and IL-23 Levels, and Other Disease Activity Parameters in Patients with Behcet's Disease

Kucuksahin O., ŞAHİN A., Yildizgoren M. T., Turgay M., Kinikli G.
WEST INDIAN MEDICAL JOURNAL , vol.69, no.9, pp.624-627, 2023 (SCI-Expanded, Scopus)

37. Audiological involvement in patients with systemic sclerosis

Turan K., Yayla M. E., Arslan M., Tokgoz Yilmaz S., Okatan E., Turgay M., et al.
MODERN RHEUMATOLOGY , vol.32, no.6, pp.1094-1101, 2022 (SCI-Expanded, Scopus) Creative Commons License

38. Does IL33/Sst2 Pathway Play a Role in the Pathogenesis of Familial Mediterranean Fever?

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Uslu Yurteri E., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.75, no.3, pp.406-412, 2022 (TRDizin)

39. AVASCULAR NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF LONG-TERM FOLLOW-UP FROM A SINGLE CENTRE

Bulat B., Eroglu D. S., Turgay T. M., Kinikli G., Ates A.
ANNALS OF THE RHEUMATIC DISEASES , pp.1364-1365, 2022 (SCI-Expanded, Scopus) Creative Commons License

40. INCIDENCE AND ASSOCIATED FACTORS OF CANCER IN PATIENTS WITH RHEUMATOID ARTHRITIS

Tasci O., Aysin M., Eroglu D. S., Aydogan A. K., Ates A., Turgay T. M., et al.
ANNALS OF THE RHEUMATIC DISEASES , pp.583-584, 2022 (SCI-Expanded, Scopus) Creative Commons License

41. EVALUATION OF DISEASE MANIFESTATIONS AND ADVERSE PREGNANCY OUTCOMES IN PREGNANCIES OF PATIENTS WITH BEHCET'S SYNDROME

Koken K., Eroglu D. S., Ates A., Kinikli G., Turgay. T. M.
ANNALS OF THE RHEUMATIC DISEASES , pp.693, 2022 (SCI-Expanded, Scopus) Creative Commons License

42. Neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio and mean platelet volume can be an indicator of subclinical inflammation in patients with Familial Mediterranean Fever

Dincer A. B. K., Guloksuz E. G. A., Sezer S., YILMAZ R., TURGAY T. M., ATEŞ A., et al.
EGYPTIAN RHEUMATOLOGIST , vol.44, no.3, pp.215-218, 2022 (ESCI, Scopus)

43. Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey

Yayla M. E., ŞAHİN EROĞLU D., USLU YURTERİ E., Dincer A. B. K., Sezer S., AYDEMİR GÜLÖKSÜZ E. G., et al.
CLINICAL RHEUMATOLOGY , vol.41, no.5, pp.1457-1463, 2022 (SCI-Expanded, Scopus)

44. Analysis of vascular involvement in 460 patients with Behc , et's syndrome: Clinical characteristics and associated factors

Torgutalp M., Şahin Eroğlu D., Sezer S., Yayla M. E., Karataş G., Uslu Yurteri E., et al.
JOINT BONE SPINE , vol.89, no.2, 2022 (SCI-Expanded, Scopus)

45. Assessment of subclinical atherosclerosis with carotid intima-media thickness in patients with scleroderma

ali s., Uludağ D. M. G., Esenboga K., TURGAY T. M., KILICKAP M.
Genel Tıp Dergisi , vol.32, no.1, pp.61-67, 2022 (Scopus, TRDizin)

46. Patients characteristics in Behcet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

Torgutalp M., Eroglu D. S., Sezer S., Yayla M. E., Karatas G., Ozel E. M., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.51, no.1, pp.50-58, 2022 (SCI-Expanded, Scopus)

47. Can Subclinical Atherosclerosis Be Assessed More Precisely in Behcet Syndrome Patients by Using a Particular Cutoff Value for Carotid Intima Media Thickness?

Uslu Yurteri E., Üstüner E., Torgutalp M., Yayla M. E., Okatan I. E., Sezer S., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.28, no.1, 2022 (SCI-Expanded, Scopus)

48. RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., YAYLA M. E., et al.
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.3, 2022 (SCI-Expanded, Scopus)

49. Causes of severe infections in patients with systemic sclerosis and associated factors

YAYLA M. E., USLU YURTERİ E., USLU YURTERİ E., Sahin D., Sezer S., Dincer A. B. K., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.6, pp.1881-1888, 2022 (SCI-Expanded, Scopus, TRDizin)

50. Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis

Yayla M. E., Balci G., USLU YURTERİ E., ŞAHİN EROĞLU D., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., et al.
CURRENT RHEUMATOLOGY REVIEWS , vol.18, no.2, pp.150-156, 2022 (ESCI, Scopus)

51. Clinical characteristics of pulmonary artery involvement in patients with Behcet's syndrome: single-centre experience of 61 patients

ŞAHİN EROĞLU D., Torgutalp M., Baysal S., ÇOLAKLAR A., Sezer S., Yayla M. E., et al.
CLINICAL RHEUMATOLOGY , vol.40, no.10, pp.4127-4134, 2021 (SCI-Expanded, Scopus)

52. Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study

Eroglu D. S., Colaklar A., Baysal S., USLU YURTERİ E., Baygul A., Sezer S., et al.
ARTHRITIS & RHEUMATOLOGY , vol.73, pp.590-592, 2021 (SCI-Expanded, Scopus)

53. The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet's Syndrome

Kocabay H. E., YAYLA M. E., ÜSTÜNER E., Yurteri E. U., Guloksuz E. A., Sezer S., et al.
ARTHRITIS & RHEUMATOLOGY , vol.73, pp.3915-3917, 2021 (SCI-Expanded, Scopus)

54. EFFECTS OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: A SINGLE-CENTRE EXPERIENCE FROM TURKEY

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., Yayla E., et al.
ANNALS OF THE RHEUMATIC DISEASES , pp.532-533, 2021 (SCI-Expanded, Scopus) Creative Commons License

55. Serum-Beta-2-Mikroglobulin-level bei Patienten mit rheumatoider Arthritis und ihre Beziehung zur Krankheitsaktivitat: Kann es als Krankheitsaktivitatsmarker verwendet werden?

Dincer A. B. K., Torgutalp M., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., USLU YURTERİ E., et al.
AKTUELLE RHEUMATOLOGIE , vol.46, no.3, pp.297-304, 2021 (SCI-Expanded, Scopus) Creative Commons License

56. CLINICAL CHARACTERISTICS OF THE PULMONARY ARTERY INVOLVEMENT IN PATIENTS WITH BEHCET'S SYNDROME: A SINGLE-CENTRE EXPERIENCE OF 61 PATIENTS

Eroglu D. S., Torgutalp M., Baysal S., Colaklar A., Sezer S., Yayla M. E., et al.
ANNALS OF THE RHEUMATIC DISEASES , pp.949-950, 2021 (SCI-Expanded, Scopus)

57. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels

Torgutalp M., Yayla M. E., Eroglu D. S., Dincer A. B. K., Yurteri E., Okatan I. E., et al.
Mediterranean Journal of Rheumatology , vol.32, no.1, pp.56-65, 2021 (Scopus) Sustainable Development

58. Share Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.

TORĞUTALP M., YAYLA M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., OKATAN İ. E., et al.
MEDITERRANEAN JOURNAL OF RHEUMATOLOGY (MJR) , vol.32, no.1, pp.56-65, 2021 (Scopus)

59. Clinical Features of Patients with Antiphospholipid Syndrome and Differences of Patients with Recurrent Thrombosis, A Single Center Retrospective Study

YAYLA M. E., yüksel m., ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., KELEŞOĞLU DİNÇER A. B., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.74, no.1, pp.52-59, 2021 (TRDizin)

60. Complete blood count derived haematological parameters do not correlate with disease activity in patients with radiographic axial spondyloarthritis

ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., YAYLA M. E., ÖZEL M., TURGAY T. M., et al.
Ulusal Romatoloji Dergisi , vol.13, 2021 (TRDizin)

61. Response to Secukinumab Treatment in Active Psoriatic Arthritis Patients- Single Center Experience

KELEŞOĞLU DİNÇER A. B., SEZER S., AYDEMİR GÜLÖKSÜZ E. G., YAYLA M. E., TORĞUTALP M., USLU YURTERİ E., et al.
Journal of Ankara University Faculty of Medicine , vol.74, 2021 (TRDizin)

62. High mobility group box-1 levels may be associated with disease activity of Behcet's disease

Donmez Guler D., Kelesoglu Dincer A. B., KARAHAN Z. C., Guler H. S., Yayla M. E., Sezer S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.5, pp.2690-2697, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

63. Early onset primary Sjogren syndrome, clinical and laboratory characteristics

Yayla M. E., Karaman Z., Torgutalp M., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., et al.
CLINICAL RHEUMATOLOGY , vol.39, no.9, pp.2689-2696, 2020 (SCI-Expanded, Scopus)

64. Evaluation of serum pregnancy associated plasma protein-A levels in patients with rheumatoid arthritis

Torgutalp M., Doğan Ö., Yayla M. E., Şahin Eroğlu D., Keleşoğlu Dinçer A. B., Sezer S., et al.
Ulusal Romatoloji Dergisi , vol.12, no.2, pp.45-50, 2020 (Peer-Reviewed Journal)

65. Romatoid artrit hastalarında serum gebelikle ilişkiliplazma protein-A düzeylerinin incelenmesi

Torgutalp M., DOĞAN Ö., Yayla M. E., Eroğlu D. Ş., Dinçer A. B. K., SEZER S., et al.
Ulusal Romatoloji Dergisi , vol.12, no.2, pp.45-50, 2020 (Peer-Reviewed Journal)

66. Idiopathic retroperitoneal fibrosis: A single center case series of 17 patients

TORĞUTALP M., DOĞAN Ö., Yayla M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., SEZER S., et al.
Ulusal Romatoloji Dergisi , vol.12, no.1, pp.22-26, 2020 (TRDizin)

67. Tofacitinib in Patients with Rheumatoid Arthritis: Single-center Experience Rheumatoid Arthritis and Tofacitinib

Yayla M. E., Şahin Eroğlu D., Torgutalp M., Sezer S., Keleşoğlu Dinçer A. B., Aydemir Gülöksüz E. G., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.73, no.1, pp.20-25, 2020 (TRDizin)

68. Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

Yayla M. E., Torgutalp M., Okatan I. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.26, no.3, pp.83-86, 2020 (SCI-Expanded, Scopus)

69. İdiyopatik retroperitoneal fibrozis: 17 olguluk tek merkez deneyimi

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Turgay T. M., et al.
Ulusal Romatoloji Dergisi , vol.12, no.1, pp.22-26, 2020 (TRDizin)

70. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis

Yayla M. E., Ilgen U., Okatan I. E., UsluYurteri E., Torgutalp M., Kelesoglu Dincer A. B., et al.
CLINICAL RHEUMATOLOGY , vol.39, no.1, pp.77-83, 2020 (SCI-Expanded, Scopus)

71. Evaluation of serum pregnancy associated plasma protein-A levels in patients with rheumatoid arthritis Romatoid artrit hastalarında serum gebelikle ilişkili plazma protein-A düzeylerinin incelenmesi

TORĞUTALP M., DOĞAN Ö., Yayla M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., SEZER S., et al.
Journal of Turkish Society For Rheumatology , vol.12, no.2, pp.45-50, 2020 (Scopus)

72. Cardiopulmonary Functions and Aerobic Capacity in Patients with Systemic Sclerosis

Kesikburun B., Koseoglu B. F., Dogan A., Sahin A., Turgay M.
CYPRUS JOURNAL OF MEDICAL SCIENCES , vol.4, no.2, pp.84-89, 2019 (ESCI, TRDizin)

73. Primary Hypertrophic Osteoarthropathy Mimicking Juvenile Idiopathic Arthritis: A Novel SLCO2A1 Mutation and Imaging Findings

Torgutalp M., Durmaz C. D., KARABULUT H. G., Seifert W., Horn D., AKKAYA Z., et al.
CYTOGENETIC AND GENOME RESEARCH , no.3, pp.126-132, 2019 (SCI-Expanded, Scopus) Creative Commons License

74. Vascular Involvement in Behcet's Syndrome May be Associated with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., Torgutalp M., Yayla M. E., Okatan I. E., Dincer A. B. K., et al.
ARTHRITIS & RHEUMATOLOGY , vol.70, 2018 (SCI-Expanded, Scopus)

75. Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis

Guven G., Guler A., ÖZYÜNCÜ N., TALAN L., HEPER A., TURGAY T. M., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.5, no.3, pp.203-205, 2018 (ESCI, TRDizin) Sustainable Development

76. PREDICTORS OF FEAR OF MOVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

KINIKLI G. İ., GÜNEY DENİZ H., KARAHAN S., ATEŞ A., Turgay M., KINIKLI G.
TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-FIZYOTERAPI REHABILITASYON , vol.29, no.2, pp.11-17, 2018 (ESCI, TRDizin) Creative Commons License

77. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

Ilgen U., Yayla M. E., Ates A., Okatan I. E., Yurteri E., Torgutalp M., et al.
LUPUS , no.4, pp.665-669, 2018 (SCI-Expanded, Scopus)

78. A GOOD MIMIC: PMR - IS PMR THE ACCURATE DIAGNOSIS? A SINGLE-CENTER STUDY

Aydin T., Isikoglu B. D., Koc O., Dincer A. B. K., Torgutalp M., Yayla M. E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , no.1, 2018 (SCI-Expanded, Scopus)

79. Sexual dysfunction in patients with systemic sclerosis

UÇAR İ., TURGAY B., KÜÇÜKŞAHİN O., Ucar E. O., TURGAY T. M.
TURKISH JOURNAL OF MEDICAL SCIENCES , no.6, pp.1104-1108, 2018 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

80. TAKAYASU'S ARTERITIS: EXPERIENCE OF A SINGLE TERTIARY CENTER

Dincer A. B. K., Torgutalp M., Guloksuz E. G. A., Yurteri E. U., Yayla M. E., Okatan I. E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , no.1, 2018 (SCI-Expanded, Scopus)

81. Predictors of fear of movement in patients with rheumatoid arthritis

KINIKLI G. İ., Deniz H. G., KARAHAN S., ATEŞ A., Turgay M., KINIKLI G.
Turkish Journal of Physiotherapy and Rehabilitation , vol.29, no.2, pp.11-17, 2018 (Scopus, TRDizin)

82. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever

KÜÇÜKŞAHİN O., YILDIZGÖREN M. T., Ilgen U., Ates A., Kinikli G., Turgay M., et al.
MODERN RHEUMATOLOGY , no.2, pp.350-355, 2017 (SCI-Expanded, Scopus)

83. PULMONER TUTULUMLU PRİMER SİSTEMİK SKLEROZDA SERUM PROKALSİTONİN DÜZEYİ ENFEKSİYÖZ PULMONER HASTALIKLARDAN AYIRDETTİRİCİ MİDİR

OKATAN İ. E., KINIKLI S., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.
RAED DERGİSİ , vol.8, pp.75-76, 2016 (TRDizin)

84. ATEŞİN NADİR BİR NEDENİ MEZENTERİK PANNİKÜLİT

KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KINIKLI G., TURGAY T. M., et al.
RAED DERGİSİ , vol.8, pp.106-107, 2016 (TRDizin)

85. RAYNAUD FENOMENİ İLE BAŞVURAN HASTALAR İLE BAĞ DOKU HASTALIĞI OLAN HASTALARIN KAPİLLOROSKOPİK VE LABORATUVAR ÖZELLİKLERİNİN KARŞILAŞTIRILMASI

TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.
RAED DERGİSİ , vol.8, pp.56, 2016 (TRDizin)

86. Effect of DMARD Therapies on NSAID Intake, Quality of Life, and Physical Functioning in Patients with Ankylosing Spondylitis

KINIKLI G., KINIKLI G. İ., KARAHAN S., Yuksek A., ATEŞ A., Turgay M.
ARTHRITIS & RHEUMATOLOGY , 2016 (SCI-Expanded, Scopus)

87. İDİYOPATİK RETROPERİTONEAL FİBROZİS 7 OLGULUK VAKA SERİSİ

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., YAYALA M. E., OKATAN İ. E., KINIKLI G., TURGAY T. M., et al.
RAED DERGİSİ , vol.8, pp.74, 2016 (TRDizin)

88. VASKÜLER BEHÇET HASTALARININ KARAKTERİSTİK ÖZELLİKLERİ

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., BAŞAKSU Ö., YALÇINER M., et al.
RAED DERGİSİ , vol.8, pp.156, 2016 (TRDizin)

89. BEHÇET HASTALIĞI TANISI İLE TAKİBEDİLEN HASTALARIN ULUSLARARASI BEHÇET HASTALIĞI TANI KRİTERLERİNE GÖRE YENİDEN DEĞERLENDİRİLMESİ

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., YAYLA M. E., ATEŞ A., TURGAY T. M., et al.
RAED DERGİSİ , vol.8, pp.55, 2016 (TRDizin)

90. ANTİFOSFOLİPİD ANTİKOR BİRLİKTELİĞİ OLAN VE OLMAYAN SİSTEMİK LUPUS ERİTEMATOZUSLU HASTALARIN AYIRDEDİCİ KLİNİK VE LABORATUVAR ÖZELLİKLERİ

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.
RAED DERGİSİ , vol.8, pp.142, 2016 (Peer-Reviewed Journal)

91. GERİATRİK POPÜLASYONDA SERUM D VİTAMİNİ DÜZEYLERİ İLE KEMİK MİNERAL YOĞUNLUĞU ARASINDAKİ İLİŞKİ ÇAPRAZ KESİTSEL BİR ÇALIŞMA The Relationship Between Serum Vitamin D Levels and Bone Mineral Density Among Geriatric Population A Cross Sectional Study

YILDIZ H. İ., YALÇIN A., ARAS S., VARLI M., ATLI T., TURGAY M.
Bozok Tıp Dergisi , vol.2, no.3, pp.8-15, 2016 (TRDizin)

92. Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey

KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., TÖRÜNER M., Turgay M., Duman T., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , no.4, pp.317-324, 2016 (SCI-Expanded, Scopus, TRDizin)

93. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort

KALYONCU U., Solmaz D., Emmungil H., YAZICI A., KAŞİFOĞLU T., Kimyon G., et al.
JOURNAL OF AUTOIMMUNITY , pp.59-63, 2016 (SCI-Expanded, Scopus)

94. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study

Oguz E. O., KÜÇÜKŞAHİN O., Turgay M., YILDIZGÖREN M. T., ATEŞ A., Demir N., et al.
CLINICAL RHEUMATOLOGY , no.3, pp.663-666, 2016 (SCI-Expanded, Scopus)

95. GERİATRİK POPÜLASYONDA SERUM D VİTAMİNİDÜZEYLERİ İLE KEMİK MİNERAL YOĞUNLUĞUARASINDAKİ İLİŞKİ ÇAPRAZ KESİTSEL BİR ÇALIŞMA

yıldız h. i., yalçın a., ARAS S., VARLI M., atlı t., TURGAY T. M.
Bozok Tıp Dergisi , 2016 (TRDizin)

96. Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever

KÜÇÜKŞAHİN O., Seker Z., ŞAHİN A., KINIKLI G., TUNCALI T., Turgay M., et al.
ARCHIVES OF RHEUMATOLOGY , no.2, pp.107-111, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

97. Neutrophilic Alveolitis and High Serum Pro-Brain Natriuretic Peptide Level may be Indicators of Pulmonary Functional Impairment in Connective Tissue Disorders

Unculu S., Diken O. E., ÇİLEDAĞ A., İKİNCİOĞULLARI K. A., KARNAK D., KAYACAN O., et al.
ARCHIVES OF RHEUMATOLOGY , no.1, pp.14-23, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

98. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis a multicentric observational study A HBV study

KALYONCU U., emmungil h., ONAT A. M., yılmaz s., KAŞİFOĞLU T., AKAR S., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , 2015 (TRDizin)

99. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A

KALYONCU U., Emmungil H., Onat A. M., Yilmaz S., Kasifoglu T., Akar S., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.2, no.4, pp.149-154, 2015 (ESCI, TRDizin) Sustainable Development

100. The Impact of Ankylosing Spondylitis in Turkey on Productivity at Work Outside Home and within the Household

Solmaz D., Cetin P., Pamuk O. N., ÇEFLE A., KESER G., ÖZTÜRK M. A., et al.
ARTHRITIS & RHEUMATOLOGY , vol.67, 2015 (SCI-Expanded, Scopus)

101. Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult-Onset Still's Disease

KALYONCU U., Solmaz D., Emmungil H., YAZICI A., KAŞİFOĞLU T., Kimyon G., et al.
ARTHRITIS & RHEUMATOLOGY , vol.67, 2015 (SCI-Expanded, Scopus)

102. The Effect of Oxidative Stress on Pulmonary Involvement in Patients with Systemic Sclerosis

ERTEN Ş., TURGAY T. M., DEVRİM E., ERGÜDER B. İ., DURAK İ., KÜÇÜKŞAHİN O., et al.
Rheumatology: Current Research , vol.5, no.04, 2015 (Peer-Reviewed Journal) Creative Commons License

103. Association of Matrix Metalloproteinases and Their Tissue Inhibitor With Disease Activity and Development in Spondyloarthropathy and Inflammatory Bowel Disease

Elmas D., ŞAHİN A., KÜÇÜKŞAHİN O., Turkcapar N., TÖRÜNER M., Cetinkaya H., et al.
ARCHIVES OF RHEUMATOLOGY , vol.30, no.3, pp.191-197, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

104. Retro-orbital granuloma associated with granulomatosis with polyangiitis: a series of nine cases

Bitik B., KILIÇ L., KÜÇÜKŞAHİN O., Sahin K., TUFAN A., KARADAĞ Ö., et al.
RHEUMATOLOGY INTERNATIONAL , vol.35, no.6, pp.1083-1092, 2015 (SCI-Expanded, Scopus)

105. SEXUAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS

Ucar I., KÜÇÜKŞAHİN O., Turgay M., Ates A., Kinikli G., Duzgun N.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.1124, 2015 (SCI-Expanded, Scopus)

106. THE ROLE OF SERUM KL-6 GLYCOPROTEIN LEVELS IN LUNG INVOLVEMENT PATIENTS WITH CONNECTIVE TISSUE DISEASES

Oktay E., KÜÇÜKŞAHİN O., Turgay M., Ates A., Demir N., ÖZDEMİR KUMBASAR Ö., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.887-888, 2015 (SCI-Expanded, Scopus)

107. THE IMPACT OF ANKYLOSING SPONDYLITIS IN TURKEY ON PRODUCTIVITY AT WORK OUTSIDE HOME AND WITHIN THE HOUSEHOLD

Solmaz D., Cetin P., Pamuk O. N., ÇEFLE A., Keser G., Ozturk M. A., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.746, 2015 (SCI-Expanded, Scopus)

108. THE RELATION BETWEEN DISEASE ACTIVITY, FINDINGS AND MEAN PLATELET VOLUME IN BEHCET'S DISEASE

Uzerk M., KÜÇÜKŞAHİN O., Turgay M., Ozturk B., Turgay B., ATEŞ A., et al.
ACTA MEDICA MEDITERRANEA , vol.31, no.6, pp.1233-1239, 2015 (SCI-Expanded, Scopus)

109. Comparison of Serum IL-23 and IL-17 Levels in Patients with Systemic Sclerosis and Healthy Subjects

Celal D., Ali S., Orhan K., Murat T. M., Nuran T., Sukran E., et al.
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.6, no.1, pp.83-87, 2015 (ESCI, Scopus, TRDizin) Creative Commons License

110. The Effects of Respiratory Muscle Weakness and Pulmonary Involvement on Functional Status, Fatigue and Health Related Quality of Life in Patients With Systemic Sclerosis

Kesikburun B., Kotseoglu B. F., Sahin A., Turgay M., Dogan A., Oken O. A.
ARCHIVES OF RHEUMATOLOGY , vol.30, no.2, pp.116-123, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

111. A rare but serious manifestation of Behcet's disease: intracardiac thrombus in 22 patients

Emmungil H., YAŞAR BİLGE N. Ş., KÜÇÜKŞAHİN O., Kilic L., Okutucu S., Gucenmez S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)

112. Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?

Ozen M., Keskin O., TOPÇUOĞLU P., Ozturk B., Ozgul S., Ilgen U., et al.
LEUKEMIA & LYMPHOMA , vol.55, no.7, pp.1697-1698, 2014 (SCI-Expanded, Scopus)

113. Pulmonary Arterial Hypertension and Systemic Sclerosis Relation: A Single Centre Experience

Demir N., Sahin A., KÜÇÜKŞAHİN O., KAYACAN O., DİNÇER İ., Sayin T., et al.
HEART LUNG AND CIRCULATION , vol.23, no.7, pp.667-673, 2014 (SCI-Expanded, Scopus)

114. Infections after Biologic Agent Therapy in rheumatic diseases

Kinikli S., Kinikli G., Kucuksahin O., Turgay M., Ates A.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.21, pp.348-349, 2014 (SCI-Expanded, Scopus) Creative Commons License

115. Tuberculosis in patients with ankylosing spondylitis treated with anti tumor necrosis factor

Kinikli G., Kucuksahin O., Turgay M., Ates A., Kinikli S.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.21, pp.355, 2014 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

116. BOSENTAN FOR DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: SINGLECENTER EXPERIENCE

KÜÇÜKŞAHİN O., Ates A., Ilgrn U., Ozturk B., Kinikli G., Turgay M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.2, 2014 (SCI-Expanded, Scopus)

117. ERAP-1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and anyklosing spondylitis

KÜÇÜKŞAHİN O., Turkcapar N., Ates A., TÖRÜNER M., Duman T., Cetinkaya H., et al.
JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded, Scopus) Creative Commons License

118. Peripheral blood mononuclear cell microchimerism in Turkish female patients with systemic sclerosis

Sahin A., ÖZKAN T., Turkcapar N., KÜÇÜKŞAHİN O., KÖKSOY E. B., Ozturk G., et al.
MODERN RHEUMATOLOGY , vol.24, no.1, pp.97-105, 2014 (SCI-Expanded, Scopus)

119. The Clinical, Laboratory Aspects, Correlations of Disease Activity Score and Treatment Choices of Ankylosing Spondylitis Patients

KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., Turgay M., KINIKLI G., Duzgun N.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)

120. Anti-Interleukin-1 Treatment In 19 Patients with Familial Mediterranean Fever

KÜÇÜKŞAHİN O., Ilgen U., ATEŞ A., Gumuskemer T., KINIKLI G., Turgay M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)

121. The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases

KÜÇÜKŞAHİN O., ATEŞ A., TÖRÜNER M., Turkcapar N., ŞAHİN A., Turgay M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)

122. The Role of Anti-Cd74 Antibody in The Development of Spondyloarthropathy in Ankylosing Spondylitis and Inflammatory Bowel Disease and Disease Activity

Yurumez S., KÜÇÜKŞAHİN O., Turgay M., ATEŞ A., TÖRÜNER M., Cetinkaya H., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)

123. Treatment Resistant Severe Digital Ischemia Associated with Antiphospholipid Syndrome in a Male Patient with Systemic Sclerosis

KÜÇÜKŞAHİN O., ATEŞ A., Alexis O., Emre K., TURGAY T. M., KINIKLI G.
Case Reports in Rheumatology , vol.2014, pp.1-3, 2014 (Peer-Reviewed Journal) Creative Commons License

124. DELAY OF DIAGNOSIS IN STILL'S DISEASE IS ASSOCIATED WITH A CHRONIC/RELAPSING PATTERN: NATIONAL, MULTICENTER STUDY OF 356 PATIENTS

KALYONCU U., Solmaz D., EMMUNGİL H., YAZICI A., Kasifoglu T., Kimyon G., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.72, pp.330, 2013 (SCI-Expanded, Scopus) Sustainable Development

125. THE RELATION BETWEEN DISEASE ACTIVITY AND FINDINGS AND MEAN PLATELET VOLUME IN BEHCET'S DISEASE

Kibar M. U., KÜÇÜKŞAHİN O., Turgay M., Kinikli G., Ates A.
ANNALS OF THE RHEUMATIC DISEASES , vol.72, pp.325, 2013 (SCI-Expanded, Scopus) Sustainable Development

126. Analjezik Antiinflamatuvar İlaçların Yan Etkilerive Bunların Yönetimi

KÜÇÜKŞAHİN O., TURGAY T. M.
İÇ HASTALIKLARI Dergisi , vol.20, no.1, pp.39-47, 2013 (Peer-Reviewed Journal)

127. Asymptomatic bacteriuria among the elderly living in the community: Prevalence, risk factors and characteristics

VARLI M., Guruz H., ARAS S., YALÇIN A., Atli T., Turgay M.
EUROPEAN GERIATRIC MEDICINE , vol.3, no.2, pp.87-91, 2012 (SCI-Expanded, Scopus)

128. The effects of dexamethasone on oxidant/antioxidant status in kidneys of rats administered mercuric chloride

Turgay M., Turgay F., Devrim E., Kucuksahin O., Caydere M., Durak I.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.113, no.1, pp.10-13, 2012 (SCI-Expanded, Scopus) Creative Commons License

129. Comparison of Different Glomerular Filtration Methods in the Elderly: Which Formula Provides Better Estimates?

ARAS S., VARLI M., Uzun B., Atli T., KEVEN K., Turgay M.
RENAL FAILURE , vol.34, no.4, pp.435-441, 2012 (SCI-Expanded, Scopus)

130. Brucellosis with p ANCA associated renal failure leukocytoclastic vasculitis and endocarditis Case report

TURGAY T. M., ERTUĞRUL E., KÜÇÜKŞAHİN O., ŞAHİN A.
Journal of Microbiology and Infectious Diseases , vol.1, no.1, pp.31-34, 2011 (Peer-Reviewed Journal)

131. Lupus panniculitis as a complication of herpes zoster

GENÇ V., GENÇ A., serdar karaca A., ÇİPE G., nergiz e., başçeken s. i., et al.
Fırat Tıp Dergisi , vol.16, no.1, pp.36-37, 2011 (TRDizin)

132. SUCCESSFULLY DELIVERED A PATIENT WITH SECONDARY APS DUE TO SLE

ŞAHİN A., TURGAY T. M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.29, no.1, pp.188, 2011 (SCI-Expanded, Scopus)

133. Effects of grape consumption on plasma and erythrocyte antioxidant parameters in elderly subjects

Avci A., Atli T., ERGÜDER B. İ., VARLI M., DEVRİM E., DEMİR Ö., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.40, no.4, pp.525-529, 2010 (SCI-Expanded, Scopus, TRDizin)

134. Detection of left ventricular systolic and diastolic functions in scleroderma patients by tissue doppler echocardiography and myocardial performance index

HÜRAL R., ÖZDEMİR O. A., Turhan S., TURGAY T. M., ÖZDOL Ç., DINÇER I., et al.
MN Kardiyoloji , vol.16, no.4, pp.225-232, 2009 (TRDizin)

135. Plasma paraoxonase activity in patients with systemic sclerosis

Erguder I. B., Erten S., DEVRİM E., Turgay M., DURAK İ.
INDIAN JOURNAL OF MEDICAL RESEARCH , vol.129, no.5, pp.609-612, 2009 (SCI-Expanded, Scopus)

136. Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis

DEVRİM E., Erten S., Erguder I. B., Namuslu M., Turgay M., DURAK İ.
MEDICAL PRINCIPLES AND PRACTICE , vol.17, no.4, pp.349-350, 2008 (SCI-Expanded, Scopus) Creative Commons License

137. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus

Turgay M., DURAK İ., ERTEN Ş., Ertugrul E., DEVRİM E., Avci A., et al.
APLAR Journal of Rheumatology , vol.10, no.2, pp.101-106, 2007 (Scopus)

138. Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: A comparative study

Ates A., Kinikli G., Turgay M., Akay G., Tokgoz G.
Clinical Rheumatology , vol.26, no.4, pp.538-545, 2007 (SCI-Expanded, Scopus) Sustainable Development

139. Lupus mastitis is not a surgical disease.

Bayar S., Dusunceli E., Ceyhan K., Uenal E., Turgay M.
The breast journal , vol.13, no.2, pp.187-8, 2007 (SCI-Expanded, Scopus)

140. Effects of apple consumption on plasma and erythrocyte antioxidant parameters in elderly subjects

Avci A., Atli T., Ergueder I. B., VARLI M., DEVRİM E., Turgay S. A. M., et al.
EXPERIMENTAL AGING RESEARCH , vol.33, no.4, pp.429-437, 2007 (SCI-Expanded, Scopus) Sustainable Development

141. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis

Pay S., Turkcapar N., Kalyoncu M., Simsek I., Beyan E., Ertenli I., et al.
Clinical Rheumatology , vol.25, no.5, pp.639-644, 2006 (SCI-Expanded, Scopus) Sustainable Development

142. Serum-soluble Fas antigen level in patients with allergic rhinitis: Its relation to specific immunotherapy

Kinikli G., Ates A., Turgay M., Aydogan N., Tokgoz G.
Allergy and Asthma Proceedings , vol.27, no.2, pp.145-147, 2006 (SCI-Expanded, Scopus)

143. Late onset rheumatoid arthritis: Clinical and laboratory comparisons with younger onset patients

Turkcapar N., Demir Ö., Atli T., Kopuk M., Turgay M., Kinikli G., et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS , vol.42, no.2, pp.225-231, 2006 (SCI-Expanded, Scopus)

144. Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients

KINIKLI G., Bektaş M., Misirlioǧlu M., ATEŞ A., Turgay M., Tuncer S., et al.
Turkish Journal of Gastroenterology , vol.16, no.3, pp.143-146, 2005 (SCI-Expanded, Scopus, TRDizin)

145. The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

ATEŞ A., KINIKLI G., Turgay M., Duman M.
CLINICAL RHEUMATOLOGY , vol.23, no.5, pp.421-425, 2004 (SCI-Expanded, Scopus)

146. The results of skin prick testing in patients with allergic rhinitis: A comparison between a multiple lancet device and a single lancet

Ates A., Kinikli G., Turgay M., Aydogan N., Duman M.
Asian Pacific Journal of Allergy and Immunology , vol.22, no.2-3, pp.109-114, 2004 (SCI-Expanded, Scopus)

147. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis

Ates A., Kinikli G., Turgay M., Duman M.
Scandinavian Journal of Immunology , vol.59, no.3, pp.315-320, 2004 (SCI-Expanded, Scopus)

148. The efficacy of viscosupplementation therapy with sodium hyaluronate in patients with knee osteoarthritis

ATEŞ A., kınıklı G., TURGAY T. M., Duman M.
Türk Geriatri Dergisi , vol.7, no.1, pp.21-24, 2004 (TRDizin)

149. HLA-DRB1 genes and disease severity in rheumatoid arthritis in Turkey

Kinikli G., Ates A., Turgay M., Akay G., Kinikli S., Tokgoz G.
Scandinavian Journal of Rheumatology , vol.32, no.5, pp.277-280, 2003 (SCI-Expanded, Scopus) Sustainable Development

150. The type and frequency of infections occurring in collagen tissue diseases

Sari R. A., Şahin M., Keskin G., Kiki I., Turgay M.
Turkish Journal of Medical Sciences , vol.31, no.4, pp.323-327, 2001 (SCI-Expanded, Scopus, TRDizin)

151. The levels of serum soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

Ates A., Kinikli G., Turgay M., Duman M.
JOURNAL OF RHEUMATOLOGY , vol.28, pp.78, 2001 (SCI-Expanded, Scopus)

152. Viscosupplementation with sodium hyaluronate for the treatment of osteoarthritis

Ates A., Kinikli G., Turgay M., Duman M.
JOURNAL OF RHEUMATOLOGY , vol.28, pp.8, 2001 (SCI-Expanded, Scopus)

153. Expression of Fas antigen (CD95) on peripheral blood lymphocytes in Behcet's disease

Ayaslioglu E., Turgay M., Duzgun N., Duman M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.18, no.4, pp.538-540, 2000 (SCI-Expanded, Scopus)

154. Systemic lupus erythematosus in Turkish men

Keskin G., Tokgoz G., Duzgun N., Duman M., Kinikli G., Olmez U., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.18, no.1, pp.114-115, 2000 (SCI-Expanded, Scopus)

155. Expression of Fas antigen (CD95) on peripheral blood lymphocytes in Behcet's disease [5]

Ayaslioglu E., Turgay T. M., Duzgun N., Duman M.
Clinical and Experimental Rheumatology , vol.18, pp.538-540, 2000 (Peer-Reviewed Journal)

156. Systemic lupus erythematosus in Turkish men [7]

Keskin G., Tokgoz G., Duzgun N., Duman M., Kinikli G., Olmez U., et al.
Clinical and Experimental Rheumatology , vol.18, pp.114-115, 2000 (Peer-Reviewed Journal)

157. Clinic and Laboratory Evaluation of our Patients with Late onset Systemic Lupus Erythematosus

KESKİN G., TOKGÖZ G., DÜZGÜN N., KINIKLI G., ÖLMEZ Ü., AYDINTUĞ A. O., et al.
TÜRKİYE TIP DERGİSİ , vol.7, no.1, pp.8-12, 2000 (Peer-Reviewed Journal)

158. Serum IFN-gamma and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis.

Keskin G., Inal A., Ali Sari R., Şengül A., ŞAHİN M., Turgay M., et al.
Allergologia et immunopathologia , vol.27, no.5, pp.261-4, 1999 (Scopus)

159. Clinical and Laboratory Features of our Male Patients with Systemic Lupus Erythematosus

KESKİN G., TOKGÖZ G., DÜZGÜN N., DUMAN M., KINIKLI G., ÖLMEZ Ü., et al.
Türkiye Tıp Dergisi , vol.6, no.5, pp.268-272, 1999 (Peer-Reviewed Journal)

160. Serum IFN-γ and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis

Keskin G., Inal A., Ali Sari R., Şengül A., Şahin M., Turgay T. M., et al.
Allergologia et Immunopathologia , vol.27, pp.261-264, 1999 (Scopus)

161. Serum immunoglobulin E (Ig E) levels after myocardial infarction

Büyükberber S., Şencan O., Büyükberber N., Tuncer C., Akyol Ö., Turgay M., et al.
Acta Cardiologica , vol.52, no.4, pp.335-345, 1997 (SCI-Expanded, Scopus) Sustainable Development

162. Human leucocyte antigens in tympanosclerosis

Dursun G., Acar A., Turgay M., Calguner M.
CLINICAL OTOLARYNGOLOGY , vol.22, no.1, pp.62-64, 1997 (SCI-Expanded, Scopus) Sustainable Development

163. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with allergic rhinoconjunctivitis

Turgay M., KESKİN G., Kminkli G., Sentürk T., Tutkak H., DUMAN M., et al.
Allergologia et Immunopathologia , vol.24, no.3, pp.129-131, 1996 (SCI-Expanded, Scopus)

164. Evaluation of interleukin 6 in rheumatoid arthritis as an activity criterion

Senturk T., Kinikli G., Turgay M., Tutkak H., Duman M., Tokgoz G.
RHEUMATOLOGY INTERNATIONAL , vol.16, no.4, pp.141-144, 1996 (SCI-Expanded, Scopus)

165. Pericardial tamponade and systemic sclerosis

Keskin G., Kulah E., Turgay M., Kinikli G., Duman M., Tokgoz G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.14, no.6, pp.701-702, 1996 (SCI-Expanded, Scopus)

166. Serum interleukin-4 (IL-4) levels in patients with allergic rhinitis and changes after short-term immunotherapy

KINIKLI G., Tulek N., Bektas A., Turgay M., Tutkak H., DUMAN M., et al.
Turkish Journal of Medical Sciences , vol.26, no.4, pp.361-363, 1996 (SCI-Expanded, Scopus, TRDizin)

167. Plasma levels of terminal complement complex in the evaluation of bioincompatibility

Duranay M., Olmez U., Turgay M., Sahin M., Bali M., Tapis Y.
NEPHRON , vol.73, no.2, pp.331, 1996 (SCI-Expanded)

168. Sistemik lupus eritematozusda anormal tiroid fonksiyon testi sonuçları

BÜYÜKBERBER S., ŞENCAN O., BÜYÜKBERBER N., BAŞEŞME E., TURGAY T. M.
İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi , vol.3, no.2, pp.80-84, 1996 (TRDizin)

169. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis

KINIKLI G., Tülek N., Sentürk T., Turgay M., Tutkak H., DUMAN M., et al.
Allergologia et Immunopathologia , vol.24, no.2, pp.65-69, 1996 (SCI-Expanded, Scopus)

170. ROMATOİD ARTRİTTE SERUM İMMÜNGLOBULİN DÜZEYLERİ IgA AKTİVİTE KRİTERİ Mİ

BÜYÜKBERBER S., TURGAY T. M., KINIKLI G., TOKGÖZ G.
TURGUT ÖZAL TIP MERKEZİ DERGİSİ , vol.3, no.1, 1996 (Peer-Reviewed Journal)

171. Plasma levels of terminal complement complex in the evaluation of bioincompatibilitya

Duranay M., ÖLMEZ Ü., Turgay M., Şahin M., Bali M., Tapış Y.
Nephron , vol.73, no.2, pp.331, 1996 (SCI-Expanded, Scopus) Creative Commons License

172. AKTİF VE İNAKTİF PSORİASİS OLGULARINDA t LENFOSİT SUBGRUPLARININ VE DOĞAL ÖLDÜRÜCÜ HÜCRELERİN DEĞERLENDİRİLMESİ

KUNDAKCI N., MURAT T. M., ERDİ H., TAŞPINAR A., TOKGÖZ G.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.48, pp.481-494, 1995 (TRDizin)

173. İnterferonlar ve Klinik Kullanımları

Çelik G., İNAL A., YALÇIN S., TURGAY T. M.
Klinik Bilimler , vol.1, no.1, pp.7-14, 1995 (Peer-Reviewed Journal)

174. Angioimmunoblastic lymphadenopathy with disproteinemia arising in a patient with rheumatoid arthritis

Özoran K., Turgay M., KINIKLI G., DUMAN M., Tolunay Ö., Tokgöz G.
Scandinavian Journal of Rheumatology , vol.24, no.1, pp.58-60, 1995 (SCI-Expanded, Scopus)

175. Case report: Computed tomography findings in lipoid proteinosis: Report of two cases

Ozbek S., Akyar S., Turgay M.
British Journal of Radiology , vol.67, no.794, pp.207-209, 1994 (SCI-Expanded, Scopus)

176. The Determination of complement activation in patients with mucocutaneous Behçets Disease

Şengül A., ÖLMEZ Ü., TURGAY T. M., Tokgöz G., Tutkak H., DÜZGÜN N., et al.
International congress series ,Behcets Disease , no.1037, pp.57-60, 1993 (Non Peer-Reviewed Journal)

177. ASSOCIATION OF HLA CLASS-I AND CLASS-II ANTIGENS WITH RHEUMATIC-FEVER IN A TURKISH POPULATION

OLMEZ U., TURGAY M., OZENIRLER S., TUTKAK H., DUZGUN N., DUMAN M., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.22, no.2, pp.49-52, 1993 (SCI-Expanded, Scopus)

178. P 136 The determination of complement activation in patients with mucocutaneous Behçet's disease

ÖLMEZ Ü., Sengül A., Turgay M., Tokgöz G., Tutkak H., Düzgün N., et al.
La Revue de medecine interne , vol.14, no.SUPPL. 1, 1993 (SCI-Expanded, Scopus)

179. HLA CLASS-I, CLASS-II DETERMINANTS IN RHEUMATOID-ARTHRITIS PATIENTS IN TURKEY

KINIKLI G., KURTAIS Y., TURGAY M., YALCIN P., ARASIL T.
BRITISH JOURNAL OF RHEUMATOLOGY , vol.31, pp.222, 1992 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences 174

1. Obstetrik AFAS Hastalarında 2006 Revize Sapporo ve 2023 ACR/EULAR Sınıflandırma Kriterlerinin Karşılaştırılması

Usta A., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
12. İYİ KLİNİSYENLİK İÇİN İPUÇLARI TOPLANTISI, Girne, Cyprus (Kktc), 12 - 14 January 2026, pp.10-13, (Full Text)

2. Sistemik Lupus Eritematozus ile takip edilen Guillain-Barre Sendromu olgusu

Ergül Ç., Sezer S., Yayla M. E., Uslu E., Usta A., Ateş A., et al.
Romatoloji Görüntüleme Sempozyumu, Antalya, Turkey, 18 - 20 April 2025, pp.37-38, (Summary Text) Creative Commons License

3. STATİN İLİŞKİLİ İMMÜN-NEKROTİZAN MİYOPATİ

Usta A., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
SPONDİLOARTRİTLER 2025, İzmir, Turkey, 18 - 21 September 2025, pp.27, (Full Text)

4. Granülomatöz Polianjit Hastalarınsa Sistemik İmmun-İnflamasyon İndeksinin Prognostik Rolü

KARAMAN ONGUN Z., USLU E., SEZER S., YAYLA M. E., TURGAY T. M., ATEŞ A.
5. Konya romatoloji sempozyumu, Konya, Turkey, 12 - 14 September 2025, pp.29-30, (Summary Text)

5. ANTISENTETAZ SENDROM ILIŞKILI INTERSTISYEL AKCIĞER HASTALIĞINDA ILK BASAMAK TEDAVI OLARAK TAKROLIMUS

Usta A., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
2. Deriden Ekleme Güncel Gelişmeler Sempozyumu , Muğla, Turkey, 1 - 04 May 2025, pp.92, (Full Text)

6. Dijital İskemi ile Başvuran Anti-PL12 / Ro52 Pozitif Antisentetaz Sendromu

Usta A., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
Romatoloj(de Hedef 2025 Sempozyumu, İstanbul, Turkey, 9 - 11 May 2025, pp.51, (Summary Text)

7. LOW-DOSE METHOTREXATE INTOXICATION IN INFLAMMATORY ARTHRITIS, CLINICAL FEATURES AND PROGNOSIS; SINGLE CENTER EXPERIENCE

Ongun Z. K., Ozden I., ERSEVER E. M., SEZER S., USLU E., ATEŞ A., et al.
EULAR European Congress of Rheumatology, Barcelona, Spain, 11 - 14 June 2025, vol.84, pp.1805-1806, (Summary Text)

8. Tedaviye Dirençli Lupus Nefriti Olgusu

Ergül Ç., Sezer S., Yayla M. E., Uslu E., Usta A., Ateş A., et al.
18. Anadolu Romatoloji Günleri, Girne, Cyprus (Kktc), 28 May - 01 June 2025, pp.64-65, (Summary Text) Creative Commons License

9. Renal tutulumu olan sistemik lupus eritematozus hastalarının demografik, klinik ve laboratuvar özellikleri, tek merkez retrospektif çalışma

Usta A., Mahmutoğlu Y., Ergül Ç., Karaman Ongun Z., Gaydan A., Göveç Gıynaş N., et al.
24. Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 - 30 October 2024, vol.16, pp.239, (Full Text)

10. Dirençli Nörobehçet Sendromunda Rituksimab Tedavisi Bir Seçenek mi? Tek Merkez Deneyimi

Karaman Ongun Z., Uslu E., Göveç Gıynaş N., Sezer S., Yayla M. E., Turgay T. M., et al.
24. Ulusal Romatoloji Kongresi, Muğla, Turkey, 26 - 30 October 2024, (Summary Text)

11. KAFA TABANI OSTEOMYELITI ILE PRESENTE OLAN GRANÜLOMATÖZ POLIANJIT OLGUSU VE LITERATÜR TARAMASI

KARAMAN ONGUN Z., USLU E., YAYLA M. E., SEZER S., ATEŞ A., TURGAY T. M.
4. Konya Romatoloji Sempozyumu, Konya, Turkey, 13 - 15 September 2024, pp.50-52, (Summary Text)

12. BEHÇET HASTALIĞINA EŞLİK EDEN DİL SKUAMÖZ HÜCRELİ KARSİNOM OLGUSU

Ergül Ç., Ateş A., Turgay T. M., Uslu E.
ANKARA ROMATOLOJİ TOPLANTISI, Sakarya, Turkey, 6 - 08 September 2024, pp.54-55, (Summary Text)

13. Güvenlik Uyarıları Öncesi ve Sonrası Tofasitinib: Tek Merkez Gerçek Yaşam Verileri

İlbay A., Uslu E., Turgay T. M., Ateş A.
ANKARA ROMATOLOJİ TOPLANTISI, Sakarya, Turkey, 6 - 08 September 2024, pp.32-34, (Summary Text)

14. İnflamatuar Artritlerde Düşük Doz Metotreksat İntoksikasyonu, Klinik Özellikleri ve Prognoz; Üçüncü Basamak Merkez Deneyimi

Karaman Ongun Z., Özden İ., Yayla M. E., Sezer S., Uslu E., Ateş A., et al.
Ankara Romatoloji Toplantısı, Sakarya, Turkey, 6 - 08 September 2024, pp.23-25, (Summary Text)

15. 2023 AMERİCAN COLLEGE OF RHEUMATOLOGY (ACR) / EUROPEAN ALLİANCE OF ASSOCİATİONS FOR RHEUMATOLOGY (EULAR) ANTİFOSFOLİPİD SENDROMU SINIFLANDIRMA KRİTERLERİNİN GERÇEK YAŞAM ROMATOLOJİ BÖLÜMÜNDEKİ PERFORMANSI

Usta A., Yayla M. E., Uslu E., Sezer S., Ateş A., Turgay T. M.
ANKARA ROMATOLOJİ TOPLANTISI, Sakarya, Turkey, 6 - 08 September 2024, pp.12-16, (Full Text)

16. AKUT EOZİNOFİLİK MİYOKARDİT İLE TANI ALAN EOZİNOFİLİK GARNÜLOMATOZİS POLİANJİTİS OLGUSU

Mahmutoğlu Y., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
ANKARA ROMATOLOJİ TOPLANTISI, Sakarya, Turkey, 6 - 08 September 2024, pp.48-49, (Summary Text)

17. ÜVEİT İLE BİRLİKTELİK GÖSTEREN JUVENİL TEMPORAL ARTERİT OLGUSU

Gaydan A., Yayla M. E., Uslu E., Sezer S., Ateş A., Turgay T. M.
ANKARA ROMATOLOJİ TOPLANTISI, Sakarya, Turkey, 6 - 08 September 2024, pp.43, (Summary Text)

18. INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURE: DEMOGRAPHIC, LABORATORY, AND CLINICAL ASPECTS; SINGLE CENTER EXPERIENCE

USLU E., İLBAY A., ŞAHİN EROĞLU D., YILMAZ R., GAYDAN A., GÖVEÇ GIYNAŞ N., et al.
EULAR 2024 congress, Austria, 12 June 2024, vol.83, pp.2036, (Summary Text)

19. EVALUATION OF CLINICAL CHARACTERISTICS OF BEHÇET SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A SINGLE CENTER EXPERIENCE FROM TURKEY

USLU E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., MAHMUTOĞLU Y., et al.
EULAR 2024 congress, Austria, 12 June 2024, vol.83, pp.1250, (Summary Text)

20. CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PRIMARY SJÖGREN’S SYNDROME: A SINGLE CENTER EXPERIENCE FROM TURKEY

KARAMAN ONGUN Z., YAYLA M. E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., et al.
EULAR 2024 congress, Austria, 12 - 15 June 2024, vol.83, pp.1698-1699, (Summary Text) Creative Commons License

21. Characteristics of Idiopathic Inflammatory Myopathy Patients with Interstitial Lung Disease: Results of A Single-Center From Turkey

İLBAY A., USLU E., GÖVEÇ GIYNAŞ N., YAYLA M. E., ŞAHİN EROĞLU D., GAYDAN A., et al.
EULAR 2024 congress, Austria, 12 June 2024, vol.83, pp.1378, (Summary Text)

22. BEHÇET HASTALIĞINDA VENA CAVA SÜPERIOR SENDROMU: OLGU SUNUMU

Mahmutoğlu Y., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
17. ANADOLU ROMATOLOJİ GÜNLERİ, Girne, Cyprus (Kktc), 5 - 09 June 2024, pp.76-77, (Full Text)

23. INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURE: DEMOGRAPHIC, LABORATORY, AND

USLU E., Ilbay A., Eroglu D. S., YILMAZ R., Gaydan A., Giynas N. G., et al.
Meeting of the European-Alliance-of-Associations-for-Rheumatology (EULAR), Vienna, Austria, 12 - 15 June 2024, vol.83, (Summary Text) Sustainable Development

24.

Karaman Ongun Z., Gaydan A., Ergül Ç., İlbay A., Göveç Gıynaş N., Usta A., et al.
Romatolojide Hedef 2024 Sempozyumu, İstanbul, Turkey, 25 - 27 April 2024, pp.28-29, (Summary Text) Creative Commons License

25. PULMONER HİPERTANSİYON İLE SEYREDEN SİSTEMİK SKLEROZİS OLGUSUNDA MACİTENTAN DENEYİMİ

Usta A., Sezer S., Yayla M. E., Uslu E., Ateş A., Turgay T. M.
SİSTEMİK SKLEROZ SEMPOZYUMU-4, Ankara, Turkey, 19 - 21 April 2024, pp.41, (Summary Text)

26. KARDİYAK TAMPONAD GELİŞEN SİSTEMİK SKLEROZ HASTASI: OLGU SUNUMU

Mahmutoğlu Y., Yayla M. E., Ateş A., Turgay T. M.
SİSTEMİK SKLEROZ SEMPOZYUMU-4, Ankara, Turkey, 19 - 21 April 2024, pp.45-46, (Full Text)

27. LUPUS PANNIKÜLITI ILE TAKIP EDILEN SUBKUTAN PANNIKÜLIT BENZERI T HÜCRELI LENFOMA OLGUSU

Ergül Ç., Ateş A., Turgay T. M.
10. İyi Klinisyenlik İçin İpuçları Toplantısı, Girne, Cyprus (Kktc), 12 - 14 January 2024, pp.39-40, (Summary Text)

28. RENAL VE ORBITA TUTULUMLU WEGENER GRANÜLOMATOZIS OLGUSU

Mahmutoğlu Y., Yayla M. E., Uslu Yurteri E., Ateş A., Turgay T. M., Kınıklı G.
Ankara Romatoloji Toplantısı, Bolu, Turkey, 8 - 10 September 2023, pp.49, (Summary Text)

29. İDİOPATİK İNFLAMATUAR MİYOPATİ HASTALARININ KLİNİK VE LABORATUVAR ÖZELLİKLERİ İLE PERİFERİK KAN İNFLAMATUAR PARAMETRELERİNİN İLİŞKİSİ; TEK MERKEZ SONUÇLARI

İlbay A., Göveç Gıynaş N., Uslu Yurteri E., Yayla M. E., Turgay T. M., Kınıklı G., et al.
Ankara Romatoloji Toplantısı, Bolu, Turkey, 8 - 10 September 2023, pp.29-30, (Summary Text)

30. SİSTEMİK SKLEROZ SEYRİ SIRASINDA AKCİĞER ADENOKARSİNOM GELİŞEN HASTA OLGUSU

Usta A., Mahmutoğlu Y., Gaydan A., Göveç Gıynaş N., İlbay A., Yayla M. E., et al.
SİSTEMİK SKLEROZ SEMPOZYUMU 3 , Mardin, Turkey, 7 - 09 July 2023, pp.63-64, (Full Text)

31. AB1462 EFFECTIVENESS OF THE STILL ACTIVITY SCORE IN ADULT-ONSET STILL’S DISEASE

Uslu Yurteri E., Yayla M. E., Atmaca Haktaniyan B., Göveç Giynaş N., Sahin Eroglu D., İlbay A., et al.
EULAR 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1959, (Summary Text)

32. İzole Retroorbital Kitle ile Tanı Alan Granülomatöz Polianjitis Olgusu

Usta A., Yücel Ceyhan E., Aydemir Gülöksüz E. G., Yayla M. E., Uslu E., Ateş A., et al.
XVII. Romatoloji Uzmanlık Öğrencileri ve Uzmanları İçin Eğitim Kursu & IX. Romatolojide Yaklaşımlar ve Profesörler ile Yuvarlak Masa Toplantıları, Antalya, Turkey, 12 - 15 January 2023, pp.30, (Summary Text)

33. IGG4 İLIŞKILI HASTALIK: TEK MERKEZ DENEYIMI

GAYDAN A., ŞAHİN EROĞLU D., USLU E., KINIKLI G., TURGAY T. M., ATEŞ A.
17. Akdeniz Romatoloji Sempozyumu, Antalya, Turkey, 1 - 04 October 2022, pp.8-9, (Summary Text)

34. Anca İlişkili Vaskülit Hastalarında Tırnak Dibi Kapilleroskopi Bulgularının Hastalık Aktivasyonu İle İlişkisi.

Arslan Kaya B., YILMAZ R., YAYLA M. E., USLU YURTERİ E., ATEŞ A., KINIKLI G., et al.
Ankara Romatoloji Toplantısı, 9 – 11 Eylül 2022, Bolu, Bolu, Turkey, 9 - 11 September 2022, (Summary Text)

35. AKSİYEL SPONDİLOARTRİTTE SEKUKİNUMAB: TEK MERKEZ 3 YILLIK GERÇEK YAŞAM VERİLERİ

ŞAHİN EROĞLU D., USLU E., AYDEMİR GÜLÖKSÜZ E. G., İLBAY A., TURGAY T. M., KINIKLI G., et al.
15. Anadolu Romatoloji Günleri, Girne, Cyprus (Kktc), 25 - 29 May 2022, pp.20, (Summary Text)

36. Aksiyel spondiloartritte sekukinumab, tek merkez 3 yıllık gerçek yşam verileri

ŞAHİN EROĞLU D., USLU YURTERİ E., AYDEMİR GÜLÖKSÜZ E. G., İLBAY A., TURGAY T. M., KINIKLI G., et al.
15. Anadolu Romatoloji Günleri, Girne, Cyprus (Kktc), 25 - 28 May 2022, (Full Text)

37. The Importance of Lower extremity vein wall thickness in patients with Behcet's Syndrome

Kocabay H. E., Yayla M. E., Üstüner E., Uslu Yurteri E., Aydemir Gülöksüz E. G., Sezer S., et al.
American College of Rheumatology Meeting Abstracts, Washington, United States Of America, 03 November 2021, (Summary Text) Creative Commons License

38. Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study.

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., SEZER S., et al.
ACR Convergence 2021, 5 - 09 November 2021, vol.73, (Summary Text)

39. Romatoid artrit ilişkili akciğer hastalığı prevalansı ve mortalite ile ilişkili faktörler: Tek merkez deneyimi

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., SEZER S., et al.
XXI. Ulusal Romatoloji Kongresi 29 Eylül-3 Ekim 2021, Antalya, Antalya, Turkey, 29 September - 03 October 2021, (Summary Text)

40. Behçet Hastalarının Klinik Özellikleriyle Sınıf 1 HLA Grupları Arasındaki İlişkinin İncelenmesi-Hla B51 Ve C16 Behçet Hastalarında Vaskuler Tutulum içın Risk Faktorü Olabilir mi?

YILMAZ R., Aksoy R., SEZER S., AYDEMİR GÜLÖKSÜZ E. G., KELEŞOĞLU DİNÇER A. B., YAYLA M. E., et al.
Ankara Romatoloji Toplantısı, 10-12 Eylül 2021, Sapanca Türkiye., Sapanca, Turkey, 10 - 12 September 2021, (Summary Text)

41. Behçet sendromlu hastalarda serum High Mobility Group Box-1 düzeyi ve bunun hastalık aktivitesi ve klinik bulgularla ilişkisi.

KELEŞOĞLU DİNÇER A. B., DÖNMEZ D., KARAHAN Z. C., GÜLER H. S., YAYLA M. E., SEZER S., et al.
Türkiye Romatoloji Derneği 2020 Ulusal Romatoloji Buluşması. 12-17 Ekim 2020 Online Kongre., Turkey, 12 - 17 October 2020, (Summary Text)

42. AB0028 Effect of genetic polymorphism of PTPN22 protein tyrosine phosphatase non receptor type 22 on progress and course of disease in familial mediterrenean fever

Seker Z., KÜÇÜKŞAHİN O., ŞAHİN A., TUNCALI T., KINIKLI G., TURGAY T. M.
EULAR 2012, 6 - 09 June 2012, vol.71, pp.639

43. POS0597 Effects Of Rıtuxımab In Patıents Wıth Rheumatoıd Arthrıtıs-Related Interstıtıal Lung Dısease: A Sıngle-Centre Experıence From Turkey.

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., YAYLA M. E., et al.
Annual European Congress of Rheumatology- EULAR 2021, 01 June 2021, vol.80, pp.532-533, (Summary Text)

44. SERUM HIGH MOBILITY GROUP BOX-1 LEVEL IN PATIENTS WITH BEHCET'S SYNDROME AND ITS RELATIONSHIP WITH DISEASE ACTIVITY AND CLINICAL FEATURES

Donmez D., Kelesoglu B., Karahan Z. C., Sezer S., Yayla M. E., Torgutalp M., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, pp.1541-1542, (Summary Text)

45. Tek merkez ankilozan spondilit ve psöriatik artrit hastalarında sekukinumab deneyimi.

KELEŞOĞLU DİNÇER A. B., GÜLÖKSÜZ E. G., TURGAY T. M., KINIKLI G., ATEŞ A.
Ulusal Romatoloji kongresi 2019, Turkey, 16 - 20 October 2019, (Summary Text) Creative Commons License

46. Behçet hastalarının klinik ve demografik karakteristikleri

ŞAHİN EROĞLU D., TORĞUTALP M., SEZER S., KOSKU H., Özel E. M., YAYLA M. E., et al.
20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

47. Vasküler Behçet hastalarının demografik ve klinik karakteristiklerinin incelenmesi: 424 hastanın retrospektif analizi.

TORĞUTALP M., ŞAHİN EROĞLU D., SEZER S., YAYLA M. E., TURGAY T. M., KINIKLI G., et al.
20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

48. Erken başlangıçlı primer Sjögren sendromu, klinik ve laboratuvar özellikleri

YAYLA M. E., KARAMAN ONGUN Z., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., SEZER S., et al.
20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

49. ANCA ilişkili vaskülitlerde enfeksiyon riski

USLU YURTERİ E., SEZER S., TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., et al.
20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Turkey, 16 - 20 October 2019, (Summary Text)

50. FRI0295 Evaluation Of Clinical Characteristics In Behcet Syndrome By Gender And Age; A Single Center Experience with 665 Patients

TORĞUTALP M., SEZER S., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., ŞAHİN EROĞLU D., et al.
Annual European Congress of Rheumatology- EULAR 2019, Madrid, Spain, 12 - 15 June 2019, vol.78, pp.828-829, (Summary Text)

51. FACTORS ASSOCIATED WITH PAIN CATASTROPHIZING IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

KINIKLI G. İ., AYDEMİR GÜLÖKSÜZ E. G., Yayla M. E., TURGAY T. M., ATEŞ A., KINIKLI G.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.656, (Summary Text) Creative Commons License

52. EVALUATION OF CLINICAL CHARACTERISTICS IN BEHCET SYNDROME BY GENDER AND AGE; A SINGLE CENTER EXPERIENCE WITH 665 PATIENTS

Torgutalp M., Sezer S., Yayla M. E., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., ŞAHİN EROĞLU D., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.828-829, (Summary Text) Creative Commons License

53. Vascular Involvement in Behcet’s Syndrome May be Associated with Subclinical Atherosclerosis

Uslu Yurteri E., Üstüner E., Torğutalp M., Yayla E. M., Okatan İ. E., Keleşoğlu Dinçer A. B., et al.
2018 ACR/ARHP Annual Meeting, Illinois, United States Of America, 19 - 24 October 2018, vol.70, no.4, pp.2993, (Full Text) Creative Commons License

54. Vascular Involvement in Behcet’s Syndrome May be Association with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., TORĞUTALP M., YAYLA M. E., OKATAN İ. E., KELEŞOĞLU DİNÇER A. B., et al.
2018 ACR/ARHP Annual Meeting, CHICAGO, United States Of America, 19 - 24 October 2018, vol.70, (Summary Text)

55. Vascular involvement şn Behcet’xxs syndrome may be associated with subclinical atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., TORĞUTALP M., Yayla M. E., OKATAN İ. E., KELEŞOĞLU DİNÇER A. B., et al.
2018 ACR/ARHP Annual Meeting, Şikago, United States Of America, 19 - 24 October 2018, vol.70, (Full Text)

56. Behçet hastalığında IL33/ST2 yolağının klinik bulgular, akut faz reaktanları ve hematolojik parametrelerle ilişkisi

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., AYDEMİR GÜLÖKSÜZ E. G., SEZER S., Yayla E. M., USLU YURTERİ E., et al.
19. Ulusal Romatoloji Kongresi, Muğla, Turkey, 26 - 30 September 2018, vol.10, pp.1-220, (Full Text)

57. BEHÇET SENDROMUNDA VASKÜLER TUTULUM VE SUBKLİNİK ATEROSKLEROZARASINDAKİ İLİŞKİ

USLU YURTERİ E., ÜSTÜNER E., TORĞUTALP M., Yayla M. E., OKATAN İ. E., KELEŞOĞLU DİNÇER A. B., et al.
19. Ulusal Romatoloji Kongresi, Muğla, Turkey, 26 - 30 September 2018, (Summary Text)

58. BEHÇET HASTALARINDA SERUM CALPROTECTİN DÜZEYİ İLE KLİNİK VE LABORATUVAROLARAK DEĞERLENDİRİLEN HASTALIK AKTİVİTE PARAMETRELERİ ARASINDAKİİLİŞKİNİN İNCELENMESİ

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., USLU YURTERİ E., OKATAN İ. E., et al.
19. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

59. Primer Sjögren sendromunda interlökin–35 düzeyi ve klinik bulgular ile ilişkisi.

YAYLA M. E., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., et al.
19.Ulusal Romatoloji Kongresi 26-30 Eylül 2018 Bodrum., Bodrum, Turkey, 26 - 30 September 2018, (Summary Text)

60. Romatoid artritli hastaların korku kaçınma inanışları ile sosyodemografik faktörler ve yaşam kalitesi arasındaki ilişki

KINIKLI G. İ., TOPAL Y., YAYLA E., Şıkşık G., Marangoz Ç., TURGAY T. M., et al.
XVII. FTR’de Gelişmeler Kongresi, Antalya, Turkey, 25 - 28 April 2018, vol.29, pp.76-77, (Summary Text)

61. Ankilozan spondilit ve romatoid artrit hastalarında b2- mikroglobulin düzeyi ve hastalık aktivitesi ile olan ilişkisi

KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., YAYLA M. E., TORĞUTALP M., SEZER S., USLU YURTERİ E., et al.
11. Anadolu Romatoloji Günleri, Antalya, Turkey, 2 - 06 May 2018, (Summary Text)

62. SAT0085 Relationship between serum calprotectin, disease activity parameters and the 7-joint ultrasound score in rheumatoid arthritis

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., YAYLA M. E., USLU YURTERİ E., OKATAN İ. E., GÜLÖKSÜZ E. G., et al.
EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

63. Comparison of physical activity, fatigue, health-related quality of life, anxiety and depression between ankylosing spondylitis and rheumatoid arthritis patients

KINIKLI G. İ., Yayla M. E., ATEŞ A., TURGAY T. M., KINIKLI G.
Annual European Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1823, (Full Text)

64. Relationship between serum calprotectin, disease activity parameters and the 7-joint ultrasound score in rheumatoid arthritis

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., Yayla M. E., USLU YURTERİ E., OKATAN İ. E., AYDEMİR GÜLÖKSÜZ E. G., et al.
Annual European Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.905, (Full Text)

65. THU0610 Serum calprotectin levels in behÇet’s disease: relationships between disease activity and clinical parameters

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., YAYLA M. E., USLU YURTERİ E., OKATAN İ. E., GÜLÖKSÜZ E. G., et al.
EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

66. AB1131 Il-33, a novel cytokine for fmf? how is it related with disease pathogenesis?

KELEŞOĞLU DİNÇER A. B., GÜLÖKSÜZ E. G., TORĞUTALP M., YAYLA M. E., USLU YURTERİ E., SEZER S., et al.
EULAR 201/8, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

67. Evaluation os serum B-2 microglobulin levels and its relationship with disease activity in rheumatoid arthritis

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., AYDEMİR GÜLÖKSÜZ E. G., Yayla M. E., USLU YURTERİ E., OKATAN İ. E., et al.
Annual European Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.273, (Full Text)

68. Serum calprotectin levels in Behçet’xxs disease: relationships between disease activity and clinical parameters

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., Yayla M. E., USLU YURTERİ E., OKATAN İ. E., AYDEMİR GÜLÖKSÜZ E. G., et al.
Annual European Congress of Rheumatology, Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.504, (Full Text)

69. THU0103 Evaluation of serum Β-2 microglobulin levels and its relationship with disease activity in rheumatoid arthritis

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., GÜLÖKSÜZ E. G., YAYLA M. E., USLU YURTERİ E., OKATAN İ. E., et al.
EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

70. AB0734 Serum il-35 levels in systemic sclerosis and relationship with clinical features

YAYLA M. E., TORĞUTALP M., OKATAN İ. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., KELEŞOĞLU DİNÇER A. B., et al.
EULAR 2018, Amsterdam, Netherlands, 13 - 16 June 2018, (Summary Text)

71. RELATIONSHIP BETWEEN SERUM CALPROTECTIN, DISEASE ACTIVITY PARAMETERS AND THE 7-JOINT ULTRASOUND SCORE IN RHEUMATOID ARTHRITIS

Torgutalp M., Dincer A. B. K., Yayla E. M., Yurteri E., Okatan E. I., Guloksuz G. E. A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.905, (Summary Text) Creative Commons License

72. IL-33, A NOVEL CYTOKINE FOR FMF? HOW IS IT RELATED WITH DISEASE PATHOGENESIS?

Dincer A. B. K., Guloksuz E. G. A., Torgutalp M., Yayla M. E., Yurteri E., Sezer S., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.1671, (Summary Text) Creative Commons License

73. COMPARISON OF PHYSICAL ACTIVITY, FATIGUE, HEALTH-RELATED QUALITY OF LIFE, ANXIETY AND DEPRESSION BETWEEN ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS PATIENTS

KINIKLI G. İ., Yayla M. E., Ates A., Turgay M., Kinikli G.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.1823, (Summary Text) Creative Commons License

74. ASSOCIATION OF HAEMATOLOGICAL PARAMETERS WITH DISEASE MANIFESTATIONS, ACTIVITY, AND SEVERITY IN PATIENTS WITH SYSTEMIC SCLEROSIS

Yayla M. E., Ilgen U., Okatan I. E., Yurteri E., Torgutalp M., Dincer A. B. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.1505, (Summary Text) Creative Commons License

75. SERUM CALPROTECTIN LEVELS IN BEHCET'S DISEASE: RELATIONSHIPS BETWEEN DISEASE ACTIVITY AND CLINICAL PARAMETERS

Torgutalp M., Dincer A. B. K., Yayla E. M., Yurteri E. U., Okatan E. I., Guloksuz G. E. A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.504, (Summary Text) Creative Commons License

76. SERUM IL-35 LEVELS IN SYSTEMIC SCLEROSIS AND RELATIONSHIP WITH CLINICAL FEATURES

Yayla M. E., Torgutalp M., Okatan I. E., Yurteri E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.1506, (Summary Text)

77. EVALUATION OF SERUM B-2 MICROGLOBULIN LEVELS AND ITS RELATIONSHIP WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS

Dincer A. B. K., Torgutalp M., Guloksuz E. G. A., Yayla M. E., Yurteri E. U., Okatan I. E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, pp.273, (Summary Text) Creative Commons License

78. Sistemik sklerozda hematolojik parametreler ile klinik bulgular, hastalık aktivitesi ve şiddeti arasındaki ilişki

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.
11. Anadolu Romatoloji Günleri, Antalya, Turkey, 2 - 06 May 2018, (Summary Text)

79. Erişkin Başlangıçlı Still Hastalığı, klinik bulguları ve tedavi sonuçları, tek merkez deneyimi

OKATAN İ. E., YAYLA M. E., SEZER S., USLU YURTERİ E., KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., et al.
11. Anadolu Romatoloji Günleri, Antalya, Turkey, 2 - 06 May 2018, pp.40, (Summary Text)

80. Romatoid Artritli Hastalarda Fiziksel Aktivite Seviyesi ile Korku Kaçınma İnanışları Arasındaki İlişki

KINIKLI G. İ., BOZGEYİK S., YAYLA E., Şıkşık G., Marangoz Ç., TURGAY T. M., et al.
XVII. FTR’de Gelişmeler Kongresi, Antalya, Turkey, 25 - 28 April 2018, (Summary Text)

81. A GOOD MIMICPMR.UIS PMR THE ACCURATE DIAGNOSIS ?A SINGLE-CENTER STUDY

AYDAN T., KOÇ O., KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., YAYLA M. E., USLU YURTERİ E., et al.
XVII MEDITERRANEAN CONGRESS OF RHEUMATOLOGY, Genoa, Italy, 12 - 14 April 2018, (Summary Text)

82. A Good Mimic: Is PMR the accurate diagnosis? A single-center study

Aydın T., Isıkoglu B., Koc O., KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., Yayla M. E., et al.
XVII. Mediterranean Congress of Rheumatology, Genoa, Italy, 12 - 14 April 2018, vol.36, pp.556, (Full Text)

83. Takayasu’s arteritis: Experience of a single tertiary center

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., AYDEMİR GÜLÖKSÜZ E. G., USLU YURTERİ E., Yayla M. E., OKATAN İ. E., et al.
XVII. Mediterranean Congress of Rheumatology, Genoa, Italy, 12 - 14 April 2018, vol.36, pp.555, (Full Text)

84. Sistemik Sklerozda Serum PAPP-A düzeyi ve klinik bulgular ile ilişkisi

YAYLA M. E., TORĞUTALP M., DOĞAN Ö., OKATAN İ. E., USLU YURTERİ E., KELEŞOĞLU DİNÇER A. B., et al.
Ankara Romatoloji Toplantısı, 6-8 Nisan 2018, Abant Bolu, Bolu, Turkey, 6 - 08 April 2018, (Summary Text)

85. IL-33, FMF' te yeni bir sitokin mi? Hastalık patogenezi ile ilişkisi

KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., TORĞUTALP M., YAYLA M. E., USLU YURTERİ E., SEZER S., et al.
Ankara Romatoloji Toplantısı, 6-8 Nisan 2018, Abant Bolu, Bolu, Turkey, 6 - 08 April 2018, (Summary Text)

86. IL-33, FMF’TE YENİ BİR SİTOKİN Mİ? HASTALIK PATOGENEZİ İLE İLİŞKİSİ

KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., TORĞUTALP M., YAYLA M. E., USLU YURTERİ E., SEZER S., et al.
Ankara Romatoloji Toplantısı 2018, Bolu, Turkey, 6 - 08 April 2018, pp.5-6, (Summary Text)

87. Osteoporozun nadir bir sebebi olarak Hajdu-Cheney Sendromu

SEZER S., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., YAYLA M. E., TORĞUTALP M., OKATAN İ. E., et al.
Ankara Romatoloji Toplantısı, 6-8 Nisan 2018, Abant Bolu, Bolu, Turkey, 6 - 08 April 2018, (Summary Text)

88. BEHÇET HASTALIĞI’NDA KLİNİK ÖZELLİKLERİN CİNSİYETE VE YAŞA GÖRE DEĞERLENDİRİLDİĞİ TEK MERKEZ 665 HASTA DENEYİMİ

TORĞUTALP M., SEZER S., Yayla M. E., KELEŞOĞLU DİNÇER A. B., AYDEMİR GÜLÖKSÜZ E. G., USLU YURTERİ E., et al.
19. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

89. Giant cell arteritis: Demographic and clinical features of 23 patients

KINIKLI G., KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., Yayla M. E., USLU YURTERİ E., OKATAN İ. E., et al.
International Internal Medicine Training Meetings-13, Bükreş, Romania, 16 - 18 March 2018, (Summary Text)

90. Romatoid artrit hastalarında serum beta-2 mikroglobulin düzeyi ve hastalık aktivasyonu ile ilişkisinin incelenmesi

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., USLU YURTERİ E., Yayla M. E., KINIKLI G., et al.
18. Ulusal Romatoloji Kongresi, Antalya, Turkey, 18 - 22 October 2017, vol.9, pp.3-4, (Summary Text)

91. FRI0315 Clinical characteristics of vascular involvement in behcet s disease

ATEŞ A., TORĞUTALP M., OKATAN İ. E., USLU YURTERİ E., KELEŞOĞLU DİNÇER A. B., YAYLA M. E., et al.
Annual European Congress of Rheumatology, EULAR 2017, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.606, (Summary Text)

92. AB0554 Relationship between disease activity and neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in behçet s disease

OKATAN İ. E., TORĞUTALP M., ATEŞ A., USLU YURTERİ E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., et al.
Annual European Congress of Rheumatology, EULAR 2017, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1244-1245, (Summary Text)

93. AB0218 Correlation of gray scale and power doppler ultrasonography with clinical evaluation in rheumatoid arthritis

OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., ATEŞ A., et al.
Annual European Congress of Rheumatology, EULAR 2017, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1124, (Summary Text)

94. THU0756-HPR Predictors of fear of movement in patients with rheumatoid arthritis

KINIKLI G. İ., GÜNEY DENİZ H., KARAHAN S., ATEŞ A., TURGAY T. M., KINIKLI G.
Poster Presentations, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1488, (Summary Text) Creative Commons License

95. CORRELATION OF GRAY SCALE AND POWER DOPPLER ULTRASONOGRAPHY WITH CLINICAL EVALUATION IN RHEUMATOID ARTHRITIS

Okatan I. E., Torgutalp M., Yayla M. E., Dincer A. B. K., Yurteri E. U., Ates A., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, pp.1124, (Summary Text) Creative Commons License

96. CLINICAL CHARACTERISTICS OF VASCULAR INVOLVEMENT IN BEHCET'S DISEASE

Ates A., Torgutalp M., Okatan E., Uslu E., Dincer B., Yayla E., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.606, (Summary Text) Creative Commons License

97. COMPARISON OF DMARD THERAPIES ON NSAID INTAKE, DISEASE ACTIVITY, FEAR OF MOVEMENT, AND QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

KINIKLI G. İ., Karahan S., Ates A., Turgay M., Kinikli G.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, pp.1538-1539, (Summary Text) Creative Commons License

98. RELATIONSHIP BETWEEN DISEASE ACTIVITY AND NEUTROPHIL-LYMPHOCYTE RATIO, PLATELET-LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN BEHCET'S DISEASE

Okatan I. E., Torgutalp M., Ates A., Yurteri E., Yayla M. E., Dincer A. B. K., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, pp.1244-1245, (Summary Text) Creative Commons License

99. EFFECT OF NSAID INTAKE ON KINESIOPHOBIA IN PATIENTS WITH ANKYLOSING SPONDYLITIS

KINIKLI G. İ., Karahan S., Ates A., Turgay M., Kinikli G.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, pp.1523-1524, (Summary Text) Creative Commons License

100. Comparison of capillaroscopic and laboratory features of patients with Raynaud's phenomenon and patients with connective tissue disease

KINIKLI G., TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.
MIRCIM 2017 & TIHUD-TIP Joint Meeting, Poland, 11 - 14 May 2017, pp.27, (Summary Text)

101. Comparison of capillaryoscopic and laboratory features of patients with Raynaud’xxs phenomenon and patients with connective tissue disease

KINIKLI G., TORĞUTALP M., OKATAN İ. E., YAYLA E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.
MIRCIM 2017 3rd Mc Master International Review Coursa in Internal Medicine, 12 - 13 May 2017, (Summary Text)

102. Antiphospholipid Antibodies in SLE patients

ATEŞ A., Yayla M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., KELEŞOĞLU DİNÇER A. B., et al.
MIRCIM 2017, 11 - 14 May 2017, (Summary Text)

103. SİSTEMİK SKLEROZİSLİ HASTALARDA ANTİ-RNA POLİMERAZ III VE DİĞER OTOANTİKORŞAR İLE KLİNİK İLİŞKİ

MÜÇTEBA ENES Y., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.
ANKARA ROMATOLOJİ GÜNLERİ, Bolu, Turkey, 14 - 16 April 2017, (Full Text)

104. ROMATOİD ARTRİTTE GRİ SKALA VE POWER DOPPLER ULTRASONOGRAFİSİNİN KLİNİK İLE İLİŞKİSİ

OKATAN İ. E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., MÜÇTEBA ENES Y., USLU YURTERİ E., ATEŞ A., et al.
ANKARA ROMATOLOJİ TOPLANTISI, Turkey, 14 - 16 April 2017, (Full Text)

105. BEL VE KALÇA AĞRISI İLE PREZANTE OLAN ERİŞKİN EWİNG SARKOMU

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., YAYLA M. E., OKATAN İ. E., USLU YURTERİ E., ATEŞ A., et al.
ANKARA ROMATOLOJİ GÜNLERİ, Turkey, 14 - 16 April 2017, (Full Text)

106. BEHÇET HASTALIĞI VE SKLEROZAN KOLANJİT BİRLİKTELİĞİ

USLU YURTERİ E., KELEŞOĞLU DİNÇER A. B., MÜÇTEBA ENES Y., TORĞUTALP M., TURGAY T. M., KINIKLI G.
ANKARA ROMATOLOJİ TOPLANTISI, Turkey, 14 - 16 April 2017, (Full Text)

107. Atipik Radyolojik Özellikli Wegener Granülomatöz Olgusu

POYRAZ B. M., AYÖZ S., ÇİFTCİ F., EROL S., Yayla M., ÇİLEDAĞ A., et al.
Ulusal Akciğer Sağlığı Kongresi, Turkey, 15 - 19 March 2017

108. IDIOPATHIC RETROPERITONEAL FIBROSIS: CASE SERIES OF 7PATIENTS

KELEŞOĞLU DİNÇER A. B., ATEŞ A., OKATAN İ. E., TORĞUTALP M., Yayla M. E., KINIKLI G., et al.
The 4th International Congress on Controversies in Rheumatology Autoimmunity, CORA 2017, 9 - 11 March 2017, (Summary Text)

109. AKUT MYELOİD LÖSEMİ VE PRİMER BİLİYER SİROZ İLE KOMPLİKE SJÖGREN SENDROMU

OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.
İYİ KLİNİSYEN İPUÇLARI TOPLANTISI, Turkey, 20 - 22 January 2017, (Full Text)

110. ATEŞIN NADIR BIR NEDENI MEZENTERIK PANNIKÜLIT

KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., TORĞUTALP M., YAYALA M. E., KINIKLI G., TURGAY T. M., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 24 - 30 October 2016, vol.8, pp.106-107, (Summary Text)

111. VASKÜLER BEHÇET HASTALARININ KARAKTERISTIKÖZELLIKLERI

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., BAŞAKSU Ö., YALÇINER M., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, 24 - 30 October 2016, (Summary Text)

112. Vasküler Behçet hastalarının karekteristik özellikleri

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., Başaksu Ö., YALÇINER M., et al.
XVII. Ulusal Romatoloji Kongresi 24-30 Ekim 2016, Antalya, Turkey, 24 - 30 October 2016

113. Antifosfolipid antikor birlikteliği olan ve olmayan sistemik lupus eritematozuslu hastaların ayırdedici klinik ve laboratuvar özellikleri

Yayla E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.
XVII. Ulusal Romatoloji Kongresi 24-30 Ekim 2016, Antalya, Turkey, 24 - 30 October 2016

114. İDIYOPATIK RETROPERITONEAL FIBROZIS 7 OLGULUK VAKA SERISI

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., YAYLA M. E., OKATAN İ. E., KINIKLI G., TURGAY T. M., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 24 - 30 October 2016, (Summary Text)

115. ANTIFOSFOLIPID ANTIKOR BIRLIKTELIĞI OLAN VE OLMAYANSISTEMIK LUPUS ERITEMATOZUSLU HASTALARIN AYIRDEDICIKLINIK VE LABORATUVAR ÖZELLIKLERI

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, 24 - 30 October 2016, (Summary Text)

116. BEHÇET HASTALIĞI TANISI İLE TAKIP EDILEN HASTALARINULUSLARARASI BEHÇET HASTALIĞI TANI KRITERLERINE GÖREYENIDEN DEĞERLENDIRILMESI

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., YAYLA E., ATEŞ A., TURGAY T. M., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, 24 October 2010 - 30 October 2016, (Summary Text)

117. RAYNOUD FENOMENI İLE BAŞVURAN HASTALAR İLE BAĞDOKU HASTALIĞI OLAN HASTALARIN KAPILLEROSKOPIK VELABORATUVAR ÖZELLIKLERININ KARŞILAŞTIRILMASI

TORĞUTALP M., OKATAN İ. E., YAYLA E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.
XVII.ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 24 - 30 October 2016, vol.8, pp.56, (Summary Text)

118. Pulmoner tutulumlu primer sistemik sklerozda serum prokalsitonin düzeyi enfeksiyöz pulmoner hastalıklardan ayırt ettirici midir

OKATAN İ. E., Kınıklı S., TORĞUTALP M., Yayla E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.
XVII. Ulusal Romatoloji Kongresi, Turkey, 24 - 30 October 2016

119. Raynaud fenomeni ile başvuran hastalar ile bağ doku hastalığı olan hastaların kapilleroskopik ve laboratuvar özelliklerinin karşılaştırılması

TORĞUTALP M., OKATAN İ. E., Yayla E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.
XVII. Ulusal Romatoloji Kongresi, Antalya, Turkey, 24 - 30 October 2016

120. PULMONER TUTLUMLU PRIMER SISTEMIK SKLEROZDASERUM PROKALSITONIN DÜZEYI ENFEKSIYÖZ PULMONERHASTALIKLARDAN AYIRT ETTIRICI MIDIR

OKATAN İ. E., KINIKLI S., TORĞUTALP M., YAYLA E., KELEŞOĞLU DİNÇER A. B., TURGAY T. M., et al.
XVII. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 24 - 30 October 2016, vol.8, pp.75, (Summary Text)

121. VASKÜLER BEHÇET HASTALARININ KARAKTERİSTİK ÖZELLİKLERİ

ATEŞ A., OKATAN İ. E., TORĞUTALP M., USLU YURTERİ E., BAŞ AKSU Ö., YALÇINER M., et al.
ULUSAL ROMATOLOJİ KONGRESİ, Turkey, 24 - 30 October 2016, vol.8, pp.156-157, (Summary Text)

122. THE CLINICAL OUTCOMES OF THE PATIENTS WITH ADULT ONSET STILL DİSEASE

ATEŞ A., KINIKLI G., TURGAY T. M., OKATAN İ. E., USLU YURTERİ E., DÜZGÜN N.
APLAR 2016, 24 - 27 October 2016, (Summary Text)

123. Raynoud fenomeni ile başvuran hastalar ile bağ doku hastalığı olan hastaların kapilleroskopik ve laboratuvar özelliklerinin karşılaştırılması.

TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.
XVII. Ulusal Romatoloji Kongresi, Antalya, Turkey, 24 - 30 October 2016, vol.8, pp.56, (Summary Text)

124. Effect of DMARD Therapies on NSAID Intake Quality of Life and Physical Functioning in Patients with Ankylosing Spondylitis

KINIKLI G., KINIKLI G. İ., KARAHAN S., ATEŞ A., TURGAY T. M.
2016 ACR/ARHP ANNUAL MEETING, Washington, Kiribati, 10 - 15 November 2016, vol.68, pp.1742, (Summary Text)

125. Behçet hastalığı tanısı ile takip edilen hastaların Uluslararası Behçet hastalığı tanı kriterlerine göre yeniden değerlendirilmesi

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., Yayla E., ATEŞ A., TURGAY T. M., et al.
XVII. Ulusal Romatoloji Kongresi, Turkey, 24 October - 30 September 2016

126. EFFECT OF LONG TERM BIOLOGIC AGENT TREATMENT ON DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS

ATEŞ A., TURGAY T. M., KINIKLI G. İ., KARAHAN S., KINIKLI S., KINIKLI G.
APLAR 2016, 26 - 29 September 2016, (Summary Text)

127. Upper extremity disability and lower extremity pain are predictors of fear of movement in patients with rheumatoid arthritis

KINIKLI G. İ., Güney H., KARAHAN S., ATEŞ A., TURGAY T. M., KINIKLI G.
18th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2016), 26 - 29 September 2016

128. Long term follow up results of treatment with biologic agents in patients with rheumatoid arthritis

KINIKLI G., ATEŞ A., KINIKLI G. İ., Kınıklı S., TURGAY T. M.
18th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2016), 26 - 29 September 2016

129. LONG TERM FOLLOW UP RESULTS OF TREATMENT WITH BIOLOGICAL AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS

KINIKLI G., ATEŞ A., KINIKLI G. İ., KINIKLI S., TURGAY T. M.
APLAR 2016, 26 - 29 September 2016, (Summary Text)

130. EFFECT OF DRUG THERAPIES ON FEAR OF MOVEMENT AND FUNCTIONAL OUTCOMES IN RHEUMATOID ARTHRITIS

KINIKLI G. İ., GÜNEY H., KARAHAN S., ATEŞ A., TURGAY T. M., KINIKLI G.
APLAR 2016, 26 - 29 September 2016, (Summary Text)

131. The clinical outcomes of the patients with adult onset Still Disease AOSD

ATEŞ A., KINIKLI G., OKATAN İ. E., USLU YURTERİ E., TURGAY T. M.
18th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2016), 26 - 29 September 2016

132. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erithematosus

İLGEN U., ATEŞ A., MÜÇTEBA ENES Y., OKATAN İ. E., USLU YURTERİ E., TURGAY T. M., et al.
15 th INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID ANTIBODIES, 21 - 24 September 2016, (Full Text)

133. Systemic lupus erythematosus with and without antiphospholipid antibodies Discriminative clinical and laboratory features

İLGEN U., ATEŞ A., Yayla E., USLU YURTERİ E., TURGAY T. M., KINIKLI G.
15th International Congress on Antiphospholipid antibodies, 21 - 24 September 2016

134. SYSTEMIC LUPUS ERYTHEMATOSUS WITH AND WITHOUT ANTIPHOSPHOLIPID ANTIBODIES DISCRIMINATIVE CLINICAL LABORATORY FEATURES

İLGEN U., ATEŞ A., YAYLA M. E., USLU YURTERİ E., TURGAY T. M., KINIKLI G.
15.INTERNATIONAL CONGRESS ON ANTIPHOSPHOLLIPID ANTIBODIES, 21 - 24 September 2016, (Summary Text)

135. THE CLINICAL AND DEMOGRAPHIC FEATURES OF RELAPSING POLYCHONDRITIS: A NATIONWIDE STUDY

Emmungil H., Erden A., KÜÇÜKŞAHİN O., Zengin O., Ermurat S., Gok K., et al.
Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, pp.569-570, (Summary Text)

136. Systemic Lupus Erythjematosus With and Without Antiphospholipid Antibodies Discriminative Clinical and Laboratory Features

İLGEN U., ATEŞ A., Yayla M. E., OKATAN İ. E., USLU YURTERİ E., TURGAY T. M., et al.
15th International Congress on Antiphospholipid Antibodies, 01 June 2016, (Summary Text)

137. Assessment of subclinical atherosclerosis with carotis intima media thickness in patients with scleroderma

Aliielkhchi S., GEREDE D. M., KILIÇKAP M., ACIBUCA A., TURGAY T. M., EROL Ç.
World Echocardiography Congress 2015-İstanbul, 20 - 22 November 2015

138. Cilt tutulumu ile başlangıç gösteren bir hemofagositik lenfohistiyositozis olgusu

güven g., güler avanoğlu a., ÖZYÜNCÜ N., talan l., HEPER A., TURGAY T. M., et al.
12. ulusal dahilive cerrahi bilimler yoğun bakım kongresi, Ankara, Turkey, 4 - 07 November 2015, (Summary Text)

139. Relapsing polikondrit hastalarının klinik ve demografik bulguları

EMMUNGİL H., KÜÇÜKŞAHİN O., ZENGİN O., ERDEN A., SARI A., DOĞRU A., et al.
XVI. Ulusal Romatoloji Kongresi, Turkey, 28 October - 01 November 2015, vol.7, pp.183, (Summary Text)

140. Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult Onset Still s Disease

KALYONCU U., SOLMAZ D., HAKAN E., YAZICI A., KAŞİFOĞLU T., GEZMİŞ K., et al.
ACR/ARHP ANNUAL MEETING 2015, 6 - 11 November 2015

141. The Role Of Serum KL 6 Glycoprotein Levels in Lung İnvolvement Patients With Connective Tissue Diseases

KÜÇÜKŞAHİN O., TURGAY T. M.
Annals Of The Rheumatic Diseases, 24 - 28 June 2015

142. THE ROLE OF SERUM KL­6 GLYCOPROTEIN LEVELS IN LUNG INVOLVEMENT PATIENTS WITH CONNECTIVE TISSUE DISEASES

OKTAY E., KÜÇÜKŞAHİN O., TURGAY T. M., ATEŞ A., DEMİR N., KINIKLI G., et al.
EULAR 2015, 16 June 2015, vol.74, pp.887-888, (Summary Text)

143. The impact of Ankylosing Spondylitis in Turkey on productivity at work outside home and within the hosehold

SOLMAZ D., ÇETİN P., PAMUK Ö. N., Cefle A., KESER G., ÖZTÜRK M. A., et al.
Annual European Congress of Rheumatology (EULAR)-2015, 10 - 13 June 2015

144. SEXUAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS

UÇAR I., KÜÇÜKŞAHİN O., TURGAY T. M., ATEŞ A., KINIKLI G., DÜZGÜN N.
EULAR 2015, 10 June 2015, vol.74, pp.1124, (Summary Text)

145. Romatoid Artritli Hastada Atipik Radyolojik Tutulum

GÜRÜN KAYA A., ÇİLEDAĞ A., KAYA A., TURGAY T. M.
Türk Toraks Derneği 18. Yıllık Kongresi, Turkey, 1 - 05 April 2015

146. THE FREQUENCY OF SPONDYLOARTHROPATHY IN INFLAMMATORY BOWEL DISEASES

KÜÇÜKŞAHİN O., Ates A., TÖRÜNER M., Turkcapar N., Sahin A., Turgay M., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.1040, (Summary Text)

147. A RARE BUT LIFE-THREATENING PRESENTATION OF BEHCET'S DISEASE: INTRA-CARDIAC THROMBUS

Emmungil H., Bilge N. Y., KÜÇÜKŞAHİN O., Kilic L., Okutucu S., Gucenmez S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.558-559, (Summary Text)

148. ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN PROSPECTIVE GENES AND SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS, INFLAMMATORY BOWEL DISEASE IN A TURKISH POPULATION

KÜÇÜKŞAHİN O., Ates A., Turkcapar N., TÖRÜNER M., Duman T., Sahin A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.807, (Summary Text)

149. Infectious Diseases after Biologic Therapy

KINIKLI S., KINIKLI G., KÜÇÜKŞAHİN O., TURGAY T. M., ATEŞ A.
16th ICID Abstracts / International Journal of Infectious Diseases, 13 April 2014, vol.21, pp.348, (Summary Text)

150. Tuberculosis in patients with ankylosing spondylitis treated with anti tumor necrosis factor

KINIKLI G., KÜÇÜKŞAHİN O., TURGAY T. M., ATEŞ A., KINIKLI S.
16th ICID, 12 April 2014, vol.21, pp.355, (Summary Text)

151. The rates of drug related side effect in patients with rheumatic diseases receiving biologic agents

KÜÇÜKŞAHİN O., TURGAY T. M., KINIKLI G., ATEŞ A., Türkçapar N., Düzgün N.
APLAR 2014, 31 March - 05 April 2014, vol.17, pp.134-144

152. BOSENTAN FOR DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: SINGLECENTER EXPERIENCE

KÜÇÜKŞAHİN O., ATEŞ A., ILGIN U., ÖZTÜRK B., KINIKLI G., TURGAY T. M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 11 March 2014, vol.32, pp.79, (Summary Text)

153. ERAP 1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and ankylosing spondylitis

KÜÇÜKŞAHİN O., TÜRKÇAPAR N., TÖRÜNER M., DUMAN T., ÇETİNKAYA H., TURGAY T. M., et al.
ECCO 2014, 20 - 22 February 2014, vol.32, pp.631, (Summary Text)

154. Atipik Başlangıçlı ve Sistemik Amiloidozis ile Seyreden Ailesel Akdeniz Ateşi Vakası

ÇOLAK S., KUBİLAY TOLUNAY P., KUMRU G., KÜÇÜKŞAHİN O., KENDİ ÇELEBİ Z., ENSARİ A., et al.
15. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 2 - 06 October 2013, (Full Text)

155. Ankilozan Spondilit Ve İnflamatuvar Bağirsak Hastaliğinda Erap 1 Gen Polimorfizminin Spondiloartropati Gelişiminde Rolü

KÜÇÜKŞAHİN O., ATEŞ A., TÜRKÇAPAR N., DUMAN M. T., TÖRÜNER M., ÇETİNKAYA H., et al.
14.Ulusal romatoloji kongresi 2013, Turkey, 11 - 15 September 2013

156. The Relation Between Disease Activity And Findings And Mean Platelet Volume In Behçet s Disease

UZERK M., KÜÇÜKŞAHİN O., TURGAY T. M., KINIKLI G., ATEŞ A.
EULAR Congress 2013, 12 - 15 June 2013

157. THE RELATION BETWEEN DISEASE ACTIVITY AND FINDINGS AND MEAN PLATELET VOLUME IN BEHCET’xxS DISEASE

KİBAR M., KÜÇÜKŞAHİN O., TURGAY T. M., KINIKLI G., ATEŞ A.
ANNALS OF THE RHEUMATIC DISEASES, 12 June 2013, vol.72, pp.325, (Summary Text)

158. DELAY OF DIAGNOSIS IN STILL’xxS DISEASE IS ASSOCIATED WITH A CHRONIC/RELAPSING PATTERN: NATIONAL, MULTICENTER STUDY OF 356 PATIENTS

KALYONCU U., SOLMAZ D., EMMUNGİL H., YAZICI A., KAŞİFOĞLU T., KİMYON G., et al.
ANNALS OF THE RHEUMATIC DISEASES - EULAR- 2013 Congress, 12 - 15 June 2013, vol.72, pp.330, (Summary Text)

159. Tumor necrosis factor inhibitors and acute leukemia in two cases.

Ozen M., Keskin O., KÜÇÜKŞAHİN O., Ilgen U., Topcuoglu P., Turgay M., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

160. Sistemik sklerozda serum PGE2 düzeylerinin pulmoner komplikasyonlarla ilişkisi

DEMİR N., AKIN KABALAK P., KÜÇÜKŞAHİN O., Demirbilek M., GÖÇMEN J. S., TURGAY T. M., et al.
Türk Toraks Derneği 16. yıllık kongresi, Antalya, Turkey, 3 - 07 April 2013, (Summary Text)

161. infamatuar bağırsak hastalarında matriks metalloproteinaz 3 matriks metalloproeinaz 9 ve metalloproteinaz 1 doku inhibitörünün spondiloartropati gelişiminde ve hastalık aktivitesindeki rolleri

ELMAS D., KÜÇÜKŞAHİN O., Türkçapar N., TÖRÜNER M., TUTKAK H., TURGAY T. M., et al.
XIII. Ulusal Romatoloji Kongresi Bildiri Özetleri Ekim 2012, Turkey, 13 - 17 October 2012, vol.4, pp.171, (Summary Text)

162. Kolşisin e bağlı myopati gelişen FMF li bir olgu sunumu

KÜÇÜKŞAHİN O., ÇAKMAK G., ÖZTÜRK UÇAR Y., ATEŞ A., TURGAY T. M.
Ulusal Romatoloji Kongresi 2012, Turkey, 13 - 17 October 2012

163. Romatoloji kliniğinde biyolojik tedavi alan romatoid artrit hastalarının tedavi yanıt oranları

KÜÇÜKŞAHİN O., ATEŞ A., KINIKLI G., TURGAY T. M., ŞAHİN A., ŞAHİN DALGIÇ G., et al.
Ulusal Romatoloji Kongresi 2012, Turkey, 13 - 17 October 2012

164. Biyolojik ajan tedavisi alan hastalarımızda yan etki oranları

KÜÇÜKŞAHİN O., ATEŞ A., KINIKLI G., TURGAY T. M., ŞAHİN A., ŞAHİN DALGIÇ G., et al.
XIII. Ulusal Romatoloji Kongresi, Turkey, 13 - 17 October 2012

165. The Relationship Between Serum Vitamin D Levels And Bone Mineral Density İn Community-Dwelling Elderly

Yıldız H., ATLI T., YALÇIN A., VARLI M., ARAS S., KARAARSLAN CENGİZ Ö., et al.
8th Congress of EUGMS Brussels, Belgium, 26 - 28 September 2012

166. Therapeutic approaches of patients with inflammatory arthritis and hepatitis B virus (AHBV study): a national multicentric study

KALYONCU U., EMMUNGİL H., Onat A. M., YILMAZ S., AKAR S., İNANÇ G. N., et al.
5th Turkish-Greek Rheumatology Days, Antalya, Turkey, 14 - 16 October 2011, (Summary Text)

167. Presentation of Drug Safety Surveillance Form and Tuberculosis and Malignancy Risk in Patients Using Anti-TNF Drugs

Aydinkarahaliloglu D., Kasap Y., Aykac E., Sagis G., Babacanoglu C., Ilbars H., et al.
11th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) on Next Stop - Istanbul-Bridging the Continents, İstanbul, Turkey, 26 - 28 October 2011, vol.34, pp.986, (Summary Text) Sustainable Development

168. Effects of apple consumption on plasma and erythrocyte antioxidant parameters in elderly subjects

ÖZTÜRK H. S., Avci A., Erguder I. B., Atli T., VARLI M., Devrim E., et al.
54th Annual Congress on Medicinal Plant Research, Helsinki, Finland, 29 August - 02 September 2006, vol.72, pp.1075, (Summary Text)

169. Nitric oxide and oxidant/antioxidant status of patients with systemic sclerosis

Devrim E., Erten S., Erguder I. B., Namuslu M., Turgay M., Durak I.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.185, (Summary Text)

170. Viscosupplementation with sodium hyaluronate for the treatment of osteoarthritis

ATEŞ A., KINIKLI G., TURGAY T. M., DUMAN M.
JOURNAL OF RHEUMATOLOGY, 12 July 2001, vol.28, pp.8, (Summary Text)

171. The levels of serum soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

ATEŞ A., KINIKLI G., TURGAY T. M., DUMAN M.
JOURNAL OF RHEUMATOLOGY, 12 July 2001, vol.28, pp.78, (Summary Text)

172. Assesment of pyrin gene mutations in Turks with familial mediterrean fever (FMF) and relationship between these mutations and HLA DR, HLA- DQ allels

KINIKLI G., BEKTAŞ M., ATEŞ A., AKAY G., TURGAY T. M., TUNCER M., et al.
FMF II: International Conference, Antalya, Turkey, 3 - 07 May 2000, (Summary Text)

173. Sjögren sendromlu olgularda artmış serum solubl intersellüler adezyon molekülü-1 (sICAM-1) düzeyleri

TURGAY T. M., YALÇIN S., ATEŞ A., KINIKLI G., DUMAN M., TOKGÖZ G.
ROMATOLOJİ 99, Turkey, 24 - 26 May 1999, (Summary Text)

174. THE DETERMINATION OF COMPLEMENT ACTIVATION IN PATIENTS WITH MUCOCUTANEOUS BEHCETS-DISEASE

SENGUL A., OLMEZ U., TURGAY M., TOKGOZ G., TUTKAK H., DUZGUN N., et al.
6th International Conference on Bechcets Disease, Paris, France, 30 June - 01 July 1993, vol.1037, pp.57-60, (Full Text)
Books 5

1. İdiyopatik İnflamatuar Miyopatiler: Klinik Bulgular ve Fenotipleri

Usta A., Turgay T. M.
in: Idiopathic Inflammatory Myopathies, Ahmet USTA,Tahsin Murat TURGAY, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.22-27, 2026

2. Romatoid Artrit Epidemiyolojisi, Klinik Özellikleri ve Tanısı

Sezer S., Turgay T. M.
in: Romatoid Artrit - 2020, Aşkın Ateş, Editor, Türkiye Klinikleri, Ankara, pp.8-13, 2020

3. Akılcı İlaç Kullanımı ROmatoloji

TURGAY T. M.
Örneklerle Akılcı İlaç UYgulamaları Kitabı, 2015

4. İmmünoloji ve romatoloji

Turgay T. M. (Editor)
Nobel Yayın Dağıtım, İstanbul, 2011

5. İmmünoloji ve romatoloji

Turgay T. M.
Nobel Yayın Dağıtım, İstanbul, 2011
Metrics

Publication

358

Publication (WoS)

159

Publication (Scopus)

135

Citation (WoS)

1079

H-Index (WoS)

17

Citation (Scopus)

1093

H-Index (Scopus)

17

Citation (Scholar)

175

H-Index (Scholar)

7

Citation (TrDizin)

13

H-Index (TrDizin)

2

Citation (Sobiad)

2

H-Index (Sobiad)

1

Citation (Sum Other)

13

Total Citation Count

1121

Project

4

Thesis Advisory

30

Open Access

65
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 4: GOAL 4: QUALITY EDUCATION
SDG 8: GOAL 8: DECENT WORK AND ECONOMIC GROWTH
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS